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 The use of a Nazarov cyclization for the diastereoselective synthesis of 
rocaglamide was studied.  Chapter 1 discusses the biological activity of the rocaglamide 
family of natural products and details the previous synthetic work on these compounds.  
Chapter 2 discusses the approaches taken in the Magnus group for the total synthesis of 
rocaglamide.  Several approaches to the natural product were undertaken.  Using a novel 
acid bromide induced Nazarov cyclization, construction of the C-ring of the natural 
product was achieved.  Attempts to construct the remainder of rocaglamide were 
ultimately unsuccessful. 
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The genus Aglaia, which consists of approximately 130 species of plants found in 
the Indo-Malaysian region, South China and on the Pacific Islands, is the source of a 
unique group of natural products consisting of a cyclopenta[b]tetrahydrobenzofuran 
skeleton.  These compounds are commonly known as the rocaglamides.  Their name was 
taken from the parent compound, rocaglamide, which was first isolated in 1982.  The 
rocaglamides have received much attention because of their remarkable biological 
activity in the areas of insecticides and anti-cancer agents.  The flowers of A. odorata 
have traditionally been used in folk medicine as a heart stimulant, febrifuge, and for the 
treatment of coughs, inflammations and injuries.  They have additionally been used as 
insect repellent in parts of South East Asia and to protect clothes from moths in 
Vietnam.1   
 
1.2 Isolation and Biological Activity 
Rocaglamide 1.2.1 was isolated from the dried stems and roots of Aglaia 
elliptifolia Merr. (Meliaceae) in 1982 by King et. al. and its structure was determined by 
X-ray crystallography.2  It was reported to exhibit significant antileukemic activity 
against P388 lymphocytic leukemia in CDF1 mice and inhibitory activity in vitro against 
cells derived from human epidermoid carcinoma of the nasopharynx (KB cell).  Since 
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then, more than 50 different rocaglamide congeners have been isolated from Aglaia spp 










































Figure 1.2.1 Representative members of the rocaglamide family 
 
 The rocaglamide family has shown a broad range of biological activities.  Almost 
all naturally occurring rocaglamide members display potent insecticidal activity, with the 
activity of the most potent being comparable to that of azadirachtin.3  More importantly 
these compounds have exhibited very good anti-tumor activity.1,4-7  The inhibition of 
numerous human cancer cell lines has been shown including A-549 (human lung 
carcinoma), RPMI-7951 (human melanoma), TE-671 (human rhabdomyosarcoma) and 
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KB cells (human cervix carcinoma) with IC50 values ranging from 1.0 - 6.0 ng/mL.8  
Rocaglamide itself has been shown to operate through a cytostatic mechanism at low 
concentrations (1-10 ng/mL)9, while triggering apoptosis in leukemia cells at higher 
concentrations (25 ng/mL).10  The rocaglamides also function as inhibitors of NF-κB 
activation in T-cells11 and as immunosuppressive phytochemicals targeting NF-AT 
activity in T-cells.12  While the compounds are potent anti-tumor agents, they show low 
toxicity toward normal cells.  All of this data makes the rocaglamides interesting 
candidates for therapeutic agents in the field of cancer.      
   
1.3 Proposed Biosynthetic Pathways to the Rocaglamides 
 Staunton proposed the first biosynthetic route to the rocaglamides in 1993.13  He 
proposed that the tricyclic core could arise from a photochemically induced [2+2] 
cycloaddition of flavone 1.3.1 and a cinnamate unit 1.3.2 to form a bicyclo [6,4] ring 
system.  This system could then undergo a rearrangement to the [5,5] system (Scheme 
1.3.1).  Experimentally, however, he found that the [2+2] cycloaddition gave exclusively 
the wrong regiochemistry 1.3.4.  Porco would later prove in his biomimetic synthesis of 




































Scheme 1.3.1 Staunton’s Biomimetic Approach 
  
 Proksch et. al.1 proposed their own hypothesis for the biogenetic origin of the 
rocaglamide skeleton (Scheme 1.3.2).  They reasoned that 3-hydroxyflavone 1.3.5 could 
perform a Michael-type addition to a cinnamide moiety to generate 1.3.6.  The resulting 
amide enolate could then attack at the C-4 carbon of the starting flavonoid to generate the 
five-membered ring of 1.3.7.  They proposed that migration of the phloroglucinol-derived 
aromatic ring could occur via electrophilic aromatic ipso-substitution to form the 
intermediate 1.3.8.  Opening of the cyclopropane could restore the aromaticity of the A-
 5 
ring yielding cyclopentanone 1.3.9.  Reduction of the ketone with a hydride source such 















































Scheme 1.3.2 Proksch’s Biosynthetic Proposal 
 
 Interestingly, the conjugate addition in nature is neither regioselective nor 
stereoselective since all four stereoisomers exist.  This information is important to note 
when designing a synthesis toward rocaglamide, since one based on a biosynthetic route 
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would most likely require the separation of multiple compounds along the synthetic 
route.  
 
1.4 Previous Studies on the Rocaglamides 
 The rocaglamides have attracted the attention of many investigators because of 
their interesting structures and significant biological activities.  To date, total syntheses of 
rocaglamide have been reported by Trost,14 Taylor,15 a process group at Novartis,16 
Porco17-19 and Frontier.33  The Trost and Porco routes are enantioselective, while the 
syntheses by Taylor, Novartis and Frontier are racemic.  
 Syntheses of other members of the rocaglamide family have also been reported.  
Aglaiastatin has been synthesized using Taylor’s approach to the core.20  Porco21 and 
Rizzacasa22,23 have both achieved total syntheses of silverstrol employing Porco’s [3+2] 
cycloaddition strategy.  There have also been numerous efforts involving various 
strategies toward the tricyclic core of the rocaglamides.24-31 
 
1.4.1 Trost’s Enantioselective Synthesis 
 The first total synthesis of rocaglamide was reported by the Trost group in 1990 
(Scheme 1.4.1).14  The synthesis began with a palladium-catalyzed cycloaddition of 
trimethylenemethane precursor 1.4.1 and oxazepinedione 1.4.2.  Subsequent hydrolysis 
of the auxiliary, esterification, and ozononlysis gave the optically pure cyclopentanone 
















Conditions: (a) Pd(OAc)2, P
iPr3, toluene; (b) NaOH, EtOH; (c) CH2N2, EtOAc; 
(d) O3, MeOH, CH2Cl2 then DMS, 85% (4 steps);
1.4.1 1.4.2 1.4.3
 
Scheme 1.4.1 Formation of the C-ring 
 
The condensation of 3,5-dimethoxyphenol and 1.4.3 with a BF3•CH3OH complex 
gave 1.4.4 as a 2:1 mixture of olefin regioisomers (Scheme 1.4.2).  Transesterification of 
one methyl ester with benzyl alcohol produced 1.4.5.  Oxidative cyclization of 1.4.5 
using DDQ occurred via an allylic cation, where the phenolic oxygen attacked at the 
position of highest positive charge, to form the tricyclic core 1.4.6.  Surprisingly, the 
approach of the phenolic oxygen occurred on the same face as the phenyl substituent.  
This was contrary to Trost’s prediction that the attack would come from the least 
hindered face, opposite the phenyl.  This result meant that additional steps were needed to 
invert the phenyl stereochemistry and obtain a cis relationship between the phenyl and 




































Conditions: (a) 3,5-dimethoxyphenol, BF3
.MeOH, CH2Cl2, 60%; (b) Ti(OBn)4, BnOH, 78%; 
(c) DDQ, THF, 75%  
Scheme 1.4.2 Formation of the tricyclic core 
 
Dihydroxylation of 1.4.6 and oxidation to the ketone, followed immediately by 
silylation and decarbobenzyloxylation gave the keto ester 1.4.7 in 60% overall yield 
(Scheme 1.4.3). To invert the C-3 stereochemistry, the enone was first installed by 
sulfenylation/dehydrosulfenylation to yield 1.4.8.  Amidation using Weinreb’s conditions 
followed by reduction of the enone with Pearlman’s catalyst resulted in a 2-3:1 mixture 
of diastereomers (1.4.9) favoring the cis orientation of the two aryl substituents.  

















































Conditions: (a) OsO4, NMO, DABCO, THF, H2O, 73%; (b) SO3
.pyridine, Et3N, DMSO;
(c) TMSOTf, iPr2NEt, benzene; (d) H2, 10% Pd/C, EtOH, 60% (3 steps); (e) NaH, PhSCl, THF;
(f) mCPBA, NaHCO3, CH2Cl2, 72% (2 steps); (g) Me2NH2Cl, Me3Al, benzene, 70-79%;
(h) H2, 20% Pd(OH)2/C, EtOH; (i) KF, MeOH; (j) Me4NB(OAc)3H, MeCN, AcOH, 50% (3 steps).  
Scheme 1.4.3 Inversion of phenyl stereochemistry and completion of synthesis 
 
 Trost’s synthesis was important because it established the absolute 
stereochemistry of (-)-rocaglamide.  It also showed the unique steric congestion present 
in the oxidative ring closure, and that a templated reduction can achieve the desired trans 
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diol present in the natural product.  However, his synthesis suffered due to its length, as 
well as, a “problematic” hydrogenation of the enone to obtain the required cis 
stereochemistry of the aryl groups. 
  
1.4.2 Taylor’s Route to Rocaglamide 
 Taylor’s approach to rocaglamide is based upon a conjugate addition of 
benzofuranone 1.4.12 to (E)-cinnamaldehyde followed by a pinacolic coupling to give 
the tricyclic core of rocaglamide.15  The synthesis began with a Houben-Hoesch reaction 
between phloroglucinol 1.4.10 and cyanohydrin 1.4.11.  Methylation of the phenolic 
oxygens with dimethyl sulfate and potassium carbonate provided benzofuranone 1.4.12 
(Scheme 1.4.4).  Conjugate addition of the benzofuranone to cinnamaldehyde using 
Triton B gave at best a 2.25:1 mixture of diastereomers 1.4.13, with the required cis 
configuration predominating.  The pinacolic coupling occurred upon treatment of the 
keto-aldehyde with SmI2 to yield 1.4.14.  The yields of this reaction, however, were 
found to be highly irreproducible, with yields ranging from 45-60%.  Oxidation of the 
secondary alcohol, followed by amide formation and selective reduction to the trans diol, 





































Conditions: (a) HCl (g), Et2O, then aq. HCl, 50-76%; (b) Me2SO4, K2CO3, acetone, then
aq. HCl, 91%; (c) E-cinnamaldehyde,Triton B, tBuOH, 69%; (d) SmI2, THF, 58%;
(e) (COCl)2, DMSO, Et3N, THF, 81%; (f) (i)TMSOTf, DIPEA, toluene (ii) LDA, HMPA, CS2, 
then MeI (iii) MeONa, THF, 55% overall; (g) Me2NLi,THF, 89%; (h) Me4NBH(OAc)3,
AcOH-MeCN, 81%.




Scheme 1.4.4 Taylor’s total synthesis of (±)-rocaglamide 
 
 Although Taylor’s synthesis was much shorter than Trost’s, it still left some room 
for improvement.  The conjugate addition gave a mixture of diastereomers that required 
separation to get the stereochemistry required in the natural product.  In addition, the 
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SmI2 promoted pinacolic coupling was not reproducible and most likely would not be 
very amenable to a large-scale synthesis.   
 
1.4.3 Novartis’ Variation on Taylor’s Route 
 A Novartis process group wanted to avoid the pinacolic coupling that Taylor had 
used because of the poor yields and low reproducibility.  A variation of Taylor’s 
synthesis was envisioned that would allow for an anionic closure of the C-ring (Scheme 
1.4.5).16  After using Taylor’s method to obtain keto-aldehyde 1.4.15, TMS-protected 
cyanohydrin 1.4.16 was formed by treatment with TMSCN and ZnI2.  Deprotonation of 
this compound with LDA caused the cyclization to form the C-ring.  Deprotection of the 
cyanohydrin with potassium carbonate then gave 1.4.17.  To install the amide moiety, the 
cyclopentanone was treated with Stiles’ reagent followed by hydrolysis of the methyl 
ester and amide coupling with dimethylamine.  Selective reduction with 



































Conditions: (a) TMSCN, ZnI2, CH3CN/benzene, quant.; (b) LDA, THF; (c) K2CO3,
MeOH, 73% (2 steps);(d) MeOMgOCO2Me, DMF; (e) 6N HCl; (f) HNMe2, Py
.BOP, 




Scheme 1.4.5 Novartis’ variation on Taylor’s approach 
 
 Although the Novartis strategy avoided the use of SmI2 to form the tricyclic core, 
the issue of diastereoselectivity in relation to the two aryl substituents had not been 
addressed.   
 
1.4.4 Porco’s [3+2] Strategy 
 Porco’s synthesis was based on the proposed biosynthesis by Proksch.17  It was 
believed that exposure of a 3-hydroxyflavone to UV light would form oxidopyryllium 
species 1.4.18 that could undergo a [3+2] cycloaddition with a cinnamic acid derivative 
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to give the aglain core 1.4.19.  This could then be converted to the rocaglamide core via 





























Scheme 1.4.6 Proposed synthetic route 
 
The synthesis began with 3-hydroxyflavone 1.4.20, which is obtained by a five 
step sequence starting from 3,5-dimethoxyphenol.18  Photoirradiation (uranium filter) 
with a 450 W medium-pressure mercury lamp in the presence of methyl cinnamate in 
methanol gave a mixture of aglain 1.4.21 in 33% yield and benzo[b]cyclobutapyran-8-
one 1.4.22 in 17% yield (Scheme 1.4.7).  It should be noted that products containing the 
opposite regiochemistry from the [3+2] and the [2+2] cycloadditions were also obtained.  
After separation of the regioisomers, the mixture of 1.4.21 and 1.4.22 was treated with 
sodium methoxide in methanol to induce the α-ketol rearrangement to 1.4.23, which was 
obtained as a mixture of compounds in 95% yield.   The two compounds were reduced to 
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the trans diols yielding methyl rocaglate 1.4.24 in 51% yield and 1.4.25 in 17% yield.  
Methyl rocaglate 1.4.24 could be converted to rocaglamide via saponification followed 





































Conditions: (a) methyl cinnamate, h! (350 nm), MeOH, 1.4.21 (33%) 1.4.22 (17%);









Scheme 1.4.7 Porco’s synthesis of the rocaglamide core 
 
Although Porco’s synthesis is the shortest to the rocaglamides, it suffers from the 
fact that the photocyclization is neither regio- nor stereoselective, thus requiring the 
separation of multiple products at two stages along the synthetic route.  This result is not 
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surprising considering all of the stereoisomers are known to exist in nature, and his 
synthesis is based on the biosynthetic proposal.  Porco later published an enantioselective 
route using chiral Brφnsted acids as mediators in the [3+2] photocyclization.19  
 
1.4.5 Frontier’s Total Synthesis of Rocaglamide 
 The Frontier group recently reported the total synthesis of (±)-rocaglamide based 
on a novel Nazarov cyclization to form the C-ring.33  Their synthesis began with 
benzofuranone 1.4.26, which was available through a three step sequence laid out by 
Taylor.15  Treatment of the benzofuranone with vinyl magnesium bromide, followed by 
dihydroxylation and periodate cleavage gave aldehyde 1.4.27 (Scheme 1.4.8).  Addition 
of lithiated phenylacetylene to the aldehyde and treatment of the resultant propargylic 


















Conditions: (a) CeCl3, vinyl magnesium bromide, then 1M HCl, 65%; (b) (i) OsO4 (4 mol%), 
NMO, acetone/t-BuOH/H2O, (ii) NaIO4, THF/H2O; (c) phenylacetylene, n-BuLi, THF;





Scheme 1.4.8 Formation of propargylic ether 
 
 Treatment of 1.4.28 with tert-butyllithium and trapping of the allenyl anion with 
tri-n-butyltin chloride gave the stannyl alkoxyallene 1.4.29, which was set up for a 
Nazarov cyclization (Scheme 1.4.9).  Upon treatment with excess m-CPBA, 
cyclopentenone 1.4.30 was formed as a single diastereomer.  The reaction was presumed 
to proceed via epoxidation of the allenyl ether to give 1.4.31, followed by opening of the 
epoxide under acidic conditions to pentadienyl cation 1.4.32, which cyclized to 1.4.30 










































Conditions: (a) t-BuLi, Bu3SnCl, Et2O; (b) m-CPBA, DMF, < 40% (over 2 steps).  
Scheme 1.4.9 Peracid initiated Nazarov cyclization 
 
 Treatment of 1.4.30 with excess DDQ resulted in the cleavage of the PMB group 
and oxidation of the benzylic position to give 1.4.33 (Scheme 1.4.10).  To introduce the 
carbonyl moiety at the C-2 position, the enol triflate was formed and subjected to 
palladium catalyzed carbonylation conditions to yield methyl ester 1.4.34.  
Hydrogenation using Trost’s conditions14 furnished cyclopentanone 1.4.35 as a single 
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diastereomer.  Templated reduction, saponification and amide formation completed the 




















































Conditions: (a) DDQ, CH2Cl2/H2O, 71%; (b) KHMDS, PhNTf2, THF, 83%; (c) Pd(PPh3)4,
CO, MeOH, iPr2EtN, THF, 83%; (d) PtO2, H2, EtOH, 65%; (e) NaHB(OAc)3, MeCN/AcOH, 
56%; (f) LiOH, THF/H2O, 82%; (g) Me2NH
.HCl, DCC, DMAP, 60%.  
Scheme 1.4.10 Completion of (±)-rocaglamide 
 
 Frontier’s synthesis was interesting as it addressed the issues that were 
encountered during previous work in the Magnus group.32  The use of an epoxide-
opening initiated Nazarov cyclization made this work novel.  
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1.5 Previous Work in the Magnus Group 
 Previous work in the Magnus group began with the question as to whether enone 
1.5.1, under equilibrating acidic or basic conditions, would open to triarylcyclone 1.5.2 
and close back onto the enone (Equation 1.5.1).32  If so, would the cis or trans orientation 















Equation 1.5.1 Equilibration via β-elimination hypothesis 
 
 The synthesis of enone 1.5.1 began with iodination of 1,3,5-trimethoxybenzene 
followed by Sonogashira coupling of the iodo derivative with 4′-methoxyphenylacetylene 
(Scheme 1.5.1).   Oxidation of the internal alkyne with RuCl3/NaIO4 introduced the 
diketone functionality in 1.5.3.  Treatment with BCl3 followed by (MeO)3CH in MeOH 
and conc. H2SO4 yielded benzofuranone 1.5.4.  Addition of the dianion of benzyl methyl 
ketone gave tertiary alcohol 1.5.5.  It was believed that treatment under acidic conditions 
would eliminate the tertiary alcohol, form the oxonium ion and cyclization would occur 
to enone 1.5.1.  However, upon treatment with p-toluenesulfonic acid in benzene, the 
only product obtained was 1.5.6.  Therefore, it was decided that a step-wise approach to 













Conditions: (a) I2, Red HgO, CH2Cl2, quant.; (b) 4-methoxyphenylacetylene,
Pd(PPh3)2Cl2, CuI, Et3N, DMF, 80%; (c) RuCl3, NaIO4, MeCN, CHCl3, H2O, 60%;
(d) BCl3, CH2Cl2, 98%; (e) MeOH, (MeO)3CH, H2SO4, quant.; (f) Benzyl methyl ketone,



















Scheme 1.5.1 First attempt at cyclization 
 
The tertiary alcohol was eliminated using Amberlyst 15 acidic ion-exchange 
resin to give enone 1.5.7 (Scheme 1.5.2).  The ketone was converted into the 




























Conditions: (a) Amberlyst 15 Acidic Resin, benzene, 94%; (b) NaH, TIPSCl, THF, 74%.
a b
 
Scheme 1.5.2 Formations of TIPS enol ether 
 
Treatment of the TIPS enol ether with SnCl4 gave the cyclization product 1.5.1 in 
50% yield and as a single diastereomer (Scheme 1.5.3).  With the desired enone in hand, 
efforts to probe the elimination/conjugate addition hypothesis were initiated.  Upon 
treatment with KOtBu/tBuOH, the deep crimson color of cyclone 1.5.2 was observed, but 
cyclization of the phenol oxygen back onto the enone could not be induced under a 




















1.5.8 1.5.1  
Scheme 1.5.3 Nazarov or Mukaiyama aldol condensation  
 
 Enone 1.5.1 was then advanced further toward rocaglamide (Scheme 1.5.4).  Silyl 
enol ether 1.5.9 was obtained via hydrosilylation using Wilkinson’s catalyst.  Desilylation 
with BnMe3NF and trapping of the enolate with N-phenyltrifluoromethanesulfonimide 
gave enol triflate 1.5.10.  Palladium catalyzed carbonylation of the vinyl triflate installed 
the ester functionality in 1.5.11.   
The oxidation of the benzylic position was next investigated.  Numerous oxidants 
were screened, however, they failed to produce the desired product.  The benzylic 
position was eventually oxidized to the peroxide upon exposure to tBuOOH in the 
presence of Darco G-60 activated carbon and K2CO3.  Reduction of the peroxide with 























Conditions: (a) Et3SiH, RhCl(PPh3)3, benzene, 88%; (b) BnMe3NF, PhNTf2, 4Å MS,
THF, 74%; (c) CO (g), Pd(OAc)2, PPh3, Et3N, MeOH, DMF, 82%; (d) t-BuOOH, DARCO, 






















Scheme 1.5.4 Formation of 1,2-anhydro methyl rocaglate 
 
 Difficulties in obtaining sufficient amounts of alcohol 1.5.12 led to the 
abandonment of this route.  However, this work was interesting in that the cyclization to 
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Chapter 2: Studies on the Total Synthesis of Rocaglamide 
 
2.0 Introduction 
Construction of the C-ring of the rocaglamides in a diastereoselective manner has 
been the focus of the Magnus group since the project began.  A promising strategy for the 
formation of this ring has involved a Nazarov cyclization.1-4  The Nazarov cyclization 
proceeds via formation of a pentadienyl cation, which under thermal conditions can 
undergo a conrotatory 4π-electron electrocyclization5 forming an allylic cation.  This 
cation can either be trapped by a nucleophile, or proton loss can occur to an alkene 










































Scheme 2.0.1 The Nazarov cyclization 
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The Nazarov reaction has been extensively studied and found to be a useful 
reaction in a number of total syntheses.6-8  All of the strategies described in this 
dissertation are focused on using a Nazarov cyclization to construct the C-ring of 
rocaglamide. 
    
2.1 Extension of Previous Magnus Group Work 
Due to problems encountered with the benzylic oxidation, as well as the fact that 
the previous route was becoming somewhat cumbersome, the route was changed slightly 
from the previous work done in the Magnus group.  It was proposed that the carbon 
analogue 2.1.1 of the TIPS-enol ether 1.5.8 might also cyclize under Lewis acidic 
conditions to 2.1.2.  The exo-methylene compound 2.1.2 might be easier to advance to 














Equation 2.1.1 Proposed cyclization route to the C-ring 
 
 Rocaglamide was envisioned coming from Taylor’s intermediate 2.1.4, which in 
turn would come from triol 2.1.3 (Scheme 2.1.1).  Dihydroxylation and hydroboration of 
2.1.2 could yield 2.1.3.  The exo-methylene compound 2.1.2 could be synthesized via 
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Nazarov cyclization of 2.1.1, which could be obtained from the alkylation/dehydration of 







































Scheme 2.1.1 Retrosynthetic Analysis 
  




















Et3N, DMF, 80 
oC
          98%
   RuCl3, NaIO4
CH3CN/CCl4/H2O
           51%
1) BCl3, CH2Cl2, 82%
2) MeOH, (MeO)3CH





Scheme 2.1.2 Synthesis of α-methoxy ketone   
  
Ketone 1.5.4 was treated with the dianion of (2-methylprop-1-enyl)benzene with 
the expectation that the alkylation would occur at the γ-carbon.  However, the major 
product of the reaction arose from alkylation at the α-carbon (relative to the phenyl).  The 
desired tertiary alcohol was isolable, albeit in a poor yield of only 22% (Equation 2.1.2).  
Interestingly, the addition of only one equivalent of butyllithium gave identical results.   














n-BuLi (2.2 eq), TMEDA
      Et2O/hexane, r.t.
               22%
Ph
2.1.5  
Equation 2.1.2 Addition of dianion into ketone   
 
 It was believed that upon treatment of 2.1.5 with a Lewis acid, dehydration would 
first occur to 2.1.1.  A Nazarov cyclization could follow to furnish the exo-methylene 
compound 2.1.2.  However, upon treatment with BCl3 in CH2Cl2, cyclization and 
fragmentation occurred to ketone 2.1.6 (Equation 2.1.3).  Unfortunately, the 
stereochemistry of the two aryl substituents, which was determined by X-ray 
crystallography, was entirely trans (See Appendix 1).  Although the wrong configuration 
was initially obtained, it was thought that this configuration might only be the kinetic 
product of addition into the oxonium ion.  Therefore, the establishment of equilibrating 
conditions was attempted using BCl3 and heat to see if the reversal of the fragmentation 
could give the desired cis configuration of the aryl substituents.  However, the harsher 













    BCl3
CH2Cl2, r.t.
     50%
2.1.6  
Equation 2.1.3 Fragmentation to trans diaryl benzofuranone 
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Since dehydration and cyclization were not occurring in the same step as planned, 
a stepwise approach to 2.1.2 was considered.  Dehydration was first performed using p-
TsCl and pyridine in 1,2-DCE to obtain diene 2.1.1 in 45% yield (Scheme 2.1.3).  
Regrettably, treatment of 2.1.1 with SnCl4 gave no reaction and BCl3 resulted in 




















    p-TsCl, pyr.
1,2-DCE, 50 oC




Scheme 2.1.3 Dehydration and attempted cyclization 
 
This route was abandoned based on the failed attempts at inducing the cyclization, 
as well as the poor yield obtained on addition of the styrene fragment to obtain the 





2.2 Epoxide Opening Strategy 
A strategy that relied on an epoxide opening to construct the 
tetrahydro[b]benzofuran ring of rocaglamide was examined next.  A Bayer research 
group reported in 2004 a stereoselective route to rocaglaol analogues using an epoxide 
opening strategy.9  It was found that a directed epoxidation of allylic alcohol 2.2.1 using 
m-CPBA gave the required epoxide stereochemistry (2.2.2) (Scheme 2.2.1).  Upon 
removal of the benzyl protecting group and opening of the epoxide by the phenolic 
oxygen, the benzofuran B-ring was formed with the desired cis configuration of the two 
aryl substituents on the C-ring (2.2.3).   This strategy, however, was never applied to the 
















   m-CPBA
CH2Cl2, 4 
oC
       67%
2.2.1 2.2.2
2.2.3  
Scheme 2.2.1 Epoxide opening to close benzofuran  
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A retrosynthetic route to rocaglamide was devised based on the work of the Bayer 
group (Scheme 2.2.2).  Rocaglamide was envisioned coming from diol 2.2.4, which was 
an intermediate in Taylor’s synthesis of rocaglamide.  The diol could be obtained from an 
epoxide opening of 2.2.5 with the epoxide being generated from a directed epoxidation of 
allylic alcohol 2.2.6.10  The alcohol could come from reduction of ketone 2.2.7 which in 
turn is derived from the introduction of the A-ring to 2.2.8.  A Nazarov cyclization of 
2.2.9 could be used to generate 2.2.8.  A promising feature of this strategy is the 











































Scheme 2.2.2 Retrosynthetic analysis       
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 With a synthetic plan laid out, the synthesis of dienone 2.2.9 was begun (Scheme 
2.2.3).  Treatment of benzaldehyde and 4′-methoxyphenylacetic acid with Et3N and Ac2O 
gave α,β-unsaturated carboxylic acid 2.2.10 in 70% yield.14,15 The acid was reacted with 
3 equivalents of lithiated ethyl vinyl ether to yield dienone 2.2.9 in 96% yield.   It is 
interesting to note that the deprotonation of ethyl vinyl ether occurred upon treatment 
with n-BuLi and TMEDA with warming to room temperature, whereas the use of t-BuLi 
for this deprotonation is widely reported in the literature.  Using n-BuLi allowed for 














    90 oC
    70%
OEt
n-BuLi, TMEDA
    0 oC to r.t.
        96%
2.2.10
 
Scheme 2.2.3 Formation of dienone for Nazarov cyclization        
  
Substrate 2.2.9 was set up nicely for a Nazarov cyclization.  α-Alkoxy dienones 
are highly reactive in Nazarov cyclizations because of the stabilizing effect that the 
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heteroatom has on the allylic cation.16-19  Conditions reported by Tius for the cyclization 
of α-alkoxy dienones using catalytic palladium(II) were examined.20  Upon treatment of 
dienone 2.2.9 with 1 mol% PdCl2(MeCN)2 in acetone, cyclized product 2.2.8 was 
obtained in 60% yield (Equation 2.2.1).  The yield of this reaction varied widely because 
of competition between hydrolysis of the enol ether and cyclization to 2.2.8.  This was 
not surprising since Tius had reported that the hydrolysis of these types of enol ethers 
















Equation 2.2.1 Palladium catalyzed cyclization 
 
Owing to the problem of hydrolysis of the enol ether under palladium catalysis, a 
protic acid was examined to induce the cyclization.  It was believed that even if the 
hydrolysis did occur, under highly acidic conditions the ketone would be in equilibrium 
with the enol tautomer and cyclization could still occur from that enol.  Introduction of 
2.2.9 to conc. H2SO4 in MeOH provided 2.2.8 in a highly reproducible yield of 95%, 











      95%
 
Equation 2.2.2 Protic acid mediated cyclization 
  
It was believed that the incorporation of the phloroglucinol derived A-ring of the 
rocaglamides could be accomplished by electrophilic aromatic substitution onto 2.2.8.   
Under strongly acidic conditions, it may be possible to establish an equilibrium between 
2.2.8 and α-diketone 2.2.12.   The diketone should be highly electrophilic for the 
aromatic ring to add into it (Scheme 2.2.4).   
Numerous conditions were employed to perform this transformation. Various 
acids (conc. H2SO4, dry HCl(g), TfOH), solvents (MeOH, Et2O) and nucleophiles 
(phloroglucinol, 3,5-dimethoxyphenol, 1,3,5-trimethoxybenzene) were screened, but 




















Scheme 2.2.4 Attempts at adding A-ring   
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Since acidic conditions did not produce the desired result, it was believed that 
halogenation of the enol may enable the formation of an α-bromo ketone that might be 
reactive towards the electrophilic aromatic substitution.  Treatment with NBS in CH2Cl2 
at room temperature gave halogenation the enol, but elimination to cyclopentenone 2.2.13 
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CH2Cl2, r.t..
    100%
 
Equation 2.2.3 Halogenation of enol 
  
 The next approach to introducing the A-ring began with reduction of the ketone.  
This would shift the enol in 2.2.8 to the keto form, of which the phloroglucinol moiety 
might add into (Scheme 2.2.5).  Upon treatment with LAH, ketone 2.2.8 was reduced to 
keto-alcohol 2.2.14 in good yield.  When this compound was treated with a Lewis (TiCl4, 
BF3•OEt2) or protic acid (conc. H2SO4, dry HCl) and a phenol (3,5-dimethoxyphenol, 
phloroglucinol), no incorporation of the aromatic group was observed.  The sole product 
obtained was cyclopentenone 2.2.15.21,22  Treatment of 2.2.14 under basic conditions, 
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THF, -78 oC




Scheme 2.2.5 Attempted addition of A-ring to keto-alcohol 
 
Approaches to incorporate the A-ring into the system did not work as planned.  
Therefore, a transition metal-catalyzed coupling reaction to install the A-ring was 
investigated.  Enol 2.2.8 was converted to enol triflate 2.2.16 in 89% yield with 








   Tf2O, Et3N
CH2Cl2, -78 
oC
         89%
 
Equation 2.2.4 Formation of enol triflate 
 
 Coupling of 1,3,5-trimethoxybenzene with the enol triflate 2.2.16 was next 
attempted (Equation 2.2.5). The palladium catalyzed Suzuki cross coupling23 of 2,4,6-
trimethoxyphenylboronic acid24 with the enol triflate was examined first.  After screening 
numerous conditions and palladium catalysts, none of the desired product was ever 
generated.  The starting enol triflate along with the deboronated aromatic were recovered 
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under the various conditions.  To avoid the proto-deboronation observed under Suzuki 
cross coupling conditions, a Negishi coupling25 was attempted using the zincated 
trimethoxybenzene.  The conditions screened for this transformation resulted in an 















M = ZnCl, B(OH)2
 
Equation 2.2.5 Attempted coupling of enol triflate 
 
Attempts at a direct coupling of 1,3,5-trimethoxybenzene, 3,5-dimethoxyphenol 
or phloroglucinol and the enol triflate with palladium catalysis only returned starting 
material.  
The directed ortho-arylation of phenols using a rhodium catalyst was also 
explored.27,28  Attempted coupling of 3,5-dimethoxyphenol and 2.2.16 using [RhCl(cod)2] 














   [RhCl(cod)2]
P(NMe2)3, K2CO3
 toluene, 100 oC
X
 
Equation 2.2.6 Directed ortho-arylation attempt 
 
It was assumed that the oxidative addition into the carbon-triflate bond was 
causing the low reactivity of the substrate.  Sorensen has previously documented 
problems associated with oxidative addition of palladium(0) into enol triflates of 
cyclopentenones.26    
At this point, the coupling strategy to the enol triflate was abandoned and the 
strategy was again reexamined.  It was thought that a more straightforward way to 
introduce the aromatic could be prior to the cyclization event.  It was believed a 
compound such as 2.2.19 could be cyclized under acidic conditions to the desired 















Equation 2.2.7 Nazarov cyclization to obtain 2.2.17 
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 To synthesize 2.2.19, the 1,2-addition of lithiated 1,3,5-trimethoxybenzene to 
dienone 2.2.9 was attempted (Equation 2.2.8).  Treatment of 1,3,5-trimethoxybenzene 
with n-BuLi and TMEDA in Et2O followed by the addition of dienone 2.2.9 gave an 
















   Et2O, 0 
oC
       then
X
 
Equation 2.2.8 Addition of lithiated 1,3,5-trimethoxybenzene to dienone 
 
 Some difficulties in this addition may have been occurring due to the hydrolysis 
of the enol ether while the dienone sat on the bench.  Therefore, incorporation of the enol 
ether at the last step in the dienol synthesis was examined to avoid this problem.   
A slightly different route needed to be taken to accomplish this (Scheme 2.2.6).  
Friedel-Crafts acylation of 1,3,5-trimethoxybenzene with 4′-methoxyphenylacetyl 
chloride gave ketone 2.2.20 in quantitative yield.  Knoevenagel condensation with 
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Scheme 2.2.6 Synthesis of enone 2.2.21   
 
 Enone 2.2.21 was treated with lithiated ethyl vinyl ether and one product was 
observed by TLC (Scheme 2.2.7).  It seemed reasonable at first that the desired dienol 
had been produced since the crude NMR spectrum showed the vinylic protons of the 
ethyl vinyl ether incorporated into the product and a crude IR spectrum showed an –OH 
stretch.  However, upon purification by column chromatography, the initial product had 
disappeared and a new compound had formed.  This product eluted as a mixture of two 
compounds that appeared to be diastereomers.  More importantly, the alcohol stretch was 
not present and the vinylic protons were gone.  The identity of the product at this point 
was unclear, until treatment with H2SO4 in dioxane gave furan 2.2.23.  The lack of an 
alcohol or carbonyl stretch in the IR spectrum and the observance of a methyl substituent 
















     H2SO4
Dioxane/H2O
 
 Scheme 2.2.7 Formation of furan 2.2.23 
  
Furan 2.2.23 arose from the 1,4-addition of ethyl vinyl ether to enone 2.2.21, 
followed by acid catalyzed ring closure onto the enol ether (Scheme 2.2.8).  Elimination 








































Scheme 2.2.8 Mechanism of formation of furan 2.2.23 
  
Treatment of the lithiated ethyl vinyl ether with CeCl3 prior to addition to the 
enone did not promote the 1,2-addition and again the 1,4-addition product was obtained.   
The epoxide opening route was also abandoned at this point as the incorporation 
the A-ring into the system proved more difficult than anticipated.  A number of methods 
were explored, but with little success. 
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2.3 Interrupted Nazarov Strategy 
 The focus of the project next shifted to a route that could potentially be very 
direct to the rocaglamide skeleton.  Taking inspiration from work published by West, it 
was believed that construction of the B- and C-rings of rocaglamide could be 
accomplished in a single step.  West had shown that dienones containing a tethered 
aromatic ring could undergo a Nazarov cyclization followed by trapping of the allylic 
cation by the aromatic to give polycyclic compounds (Scheme 2.3.1).29-31  When the 
allylic cation is trapped by a nucleophile subsequent to a Nazarov cyclization, it is termed 

































  Scheme 2.3.1 West’s interrupted Nazarov cyclizations 
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 Although West used the tethered aromatics to form 6-membered rings upon 
capture of the allylic cations, we were hopeful that the same principle could operate for 
the formation of the 5-membered furan B-ring of rocaglamide. 
 The retrosynthetic plan was laid out as follows (Scheme 2.3.2).  Rocaglamide was 
envisioned coming from the cyclopentanone 2.3.1 that could be made by an interrupted 
Nazarov reaction of dienone 2.3.2.  This dienone could be synthesized by Horner-
Wadsworth-Emmons olefination of the β-keto phosphonate derived from ester 2.3.3.  





































2.3.3 2.3.4  
Scheme 2.3.2 Retrosynthetic analysis 
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The synthesis started with the formation of activated ester 2.3.4.  This ester was 
readily available by treatment of lithiated 4′-methoxyphenylacetylene with methyl 






   n-BuLi, THF
       -78 oC
    
  then ClCO2Me
   -78 oC to r.t.
          78%
2.3.4
 
Equation 2.3.1 Formation of activated acetylene 
 
 Conditions to promote the conjugate addition of a phenol to this acetylene were 
examined.  This transformation was first attempted under basic conditions since these 
conditions are well-precedented.32-34  Treatment of 3,5-dimethoxyphenol with potassium 
tert-butoxide and 18-crown-6 in THF at 0 oC, followed by the addition of acetylene 2.3.4 
and heating to 65 oC, yielded the desired 1,4-adduct 2.3.3 as a mixture of double bond 
isomers in 41% yield.  tert-Butyl ester 2.3.5 was also formed in 20% yield (Equation 
2.3.2).   The formation of the tert-butyl ester was believed to arise from the lack of 
protons available to protonate the enolate formed upon 1,4-addition of the phenol.  A 
mixture of t-BuOH and THF prevented the formation of 2.3.5, but the yield of 2.3.3 still 
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40-45% 20%  
Equation 2.3.2 Addition of phenolate to activated acetylene 
 
 Due to less than satisfactory yields of 2.3.3, a search for an alternative method to 
improve the conjugate addition ensued.  In 2006, a paper was published using DABCO as 
a catalyst for the 1,4-addition of nucleophiles to activated alkynes.35  The proposed 
mechanism states that conjugate addition of DABCO to the substrate activates the β-
position toward nucleophilic addition (Scheme 2.3.3).  Attack of the nucleophile at the β-
position gives a zwitterionic intermediate, which upon elimination of DABCO, generates 
the β-substituted enone. 
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R3 CO2R1 + R2XH
DABCO (10 mol %)

























Scheme 2.3.3 Mechanism of DABCO catalyzed conjugate addition   
 
 Using this method, it was found that heating 3,5-dimethoxyphenol and acetylene 
2.3.4 in wet DMF with a catalytic amount of 1,4-diazabicyclo[2.2.2]octane resulted in the 
formation of desired enone 2.3.3 in quantitative yield (Scheme 2.3.4).  The product was 
isolated as a 5:1 mixture of double bond isomers, where the major isomer was believed to 
be the trans compound, with respect to the anisyl and ester groups.  This assumption was 














    97%
OMe2.3.4 2.3.3
 
Scheme 2.3.4 Conjugate addition using DABCO 
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 The mixture of double bond isomers was of little concern at this point since 
isomerization of double bonds under the conditions used to induce a Nazarov cyclization 
is known.8  The desired stereochemistry of the two aryl substituents upon cyclization 
might still be obtained because of this isomerization.   
 Ester 2.3.3 was treated with lithiated dimethyl methylphosphonate to obtain β-
keto phosphonate 2.3.6 as a mixture of double bond isomers (Scheme 2.3.5).  Horner-
Wadsworth-Emmons olefination was carried out using sodium hydride and benzaldehyde 
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Scheme 2.3.5 Formation of the dienone for cyclization     
 
 At this point the interrupted Nazarov cyclization hypothesis could be tested.  It 
was believed that treatment with a Lewis acid would cause the formation of pentadienyl 
cation 2.3.7 (Scheme 2.3.6).  A conrotatory electrocyclization could then take place to 
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allylic cation 2.3.8, which may be trapped by the electron rich aromatic, via electrophilic 
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Scheme 2.3.6 Proposed mechanism of the interrupted Nazarov cyclization  
 
 When dienone 2.3.2 was introduced to TiCl4 in dichloromethane at -78 oC 
followed by warming to room temperature, none of cyclopentanone 2.3.9 was observed.  
Cyclization of the aromatic onto the carbonyl of the dienone occurred instead, yielding 
2.3.10 (Equation 2.3.3).  This was not surprising since formation of the 6-membered ring 
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CH2Cl2, -78 
oC to r.t.





2.3.2 2.3.10  
Equation 2.3.3 Attempted Nazarov cyclization 
 
 Treatment of dienone 2.3.2 with concentrated H2SO4 in CH2Cl2, resulted in 
fragmentation of the molecule, and 3,5-dimethoxyphenol and ketone 2.3.11 were the only 
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Equation 2.3.4 Fragmentation under protic acid conditions     
 
 The fragmentation occurred first by protonation of the carbonyl group and 
formation of oxonium ion 2.3.12 (Scheme 2.3.7).  Addition of water into the oxonium ion 
gave acetal 2.3.13.  Finally, fragmentation of the acetal occurred with loss of 3,5-
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Scheme 2.3.7 Mechanism of fragmentation  
 
 Since cyclization onto the carbonyl of the aromatic group was happening under 
Lewis acidic conditions and fragmentation occurring under protic acid conditions, a way 
to possibly overcome these issues could be via acylation.  It was believed that acylation 
of the carbonyl with a bulky acylating agent such as trimethylacetyl chloride, might 
prevent the addition of the aromatic into the carbonyl due to steric hindrance.  
Additionally, the anhydrous conditions might prevent the fragmentation seen with protic 
acids. 
 This hypothesis was tested by heating dienone 2.3.2 and trimethylacetyl chloride 
in 1,2-DCE at 100 oC until all of the starting material was consumed (Equation 2.3.5).  
Unfortunately, the acylated fragmentation product 2.3.14 and 3,5-dimethoxyphenol were 
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the only products obtained.  These products could potentially arise from chloride addition 
into the oxonium ion after acylation of the carbonyl, which upon aqueous workup, 

















   sealed tube
 
Equation 2.3.5 Acylation and fragmentation of dienone    
 
A strategy was needed to make the dienone more reactive toward cyclization. The 
activation energy of the Nazarov cyclization needed to be lowered to encourage the 
cyclization to occur over attack at the carbonyl.  
 Methods of decreasing the activation energy of a Nazarov cyclization are known 
by incorporating an electron-withdrawing group at the α-position of one of the enones 
(Scheme 2.3.8).36,37  Placing an electron-withdrawing group at one α-position of the 
dienone makes this double bond more electrophilic, while the other double bond is more 
nucleophilic.  This polarization lowers the activation energy of the Nazarov cyclization, 
and it can be induced by weak Lewis acids such as Cu(OTf)2.  Weak protic acids, like 
























Scheme 2.3.8 Polarization of dienone for Nazarov cyclization 
 
 To determine if polarization of the dienone would solve the problems that had 
previously been encountered, a dienone with an electron-withdrawing group at the α-
position was synthesized.  A nitrile was introduced at the α-position starting from ester 
2.3.3.  The addition of lithiated acetonitrile to methyl ester 2.3.3 at -78 oC yielded 36% of 
the desired keto-nitrile 2.3.15.  Treatment of 2.3.15 with benzaldehyde and silica gel in 
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Scheme 2.3.9 Synthesis of α-cyano dienone 
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 Unfortunately, polarization of the dienone did not solve the problem of attack at 
the carbonyl.  When dienone 2.3.16 was exposed to TiCl4 in dichloromethane at -78 oC, 



















Equation 2.3.6 Attempted cyclization of α-cyano dienone 
 
 It was reasoned that cyclization into the carbonyl may be occurring because of the 
proximity of the electron-rich aromatic to the carbonyl (Figure 2.3.1).  It was presumed 
that the conjugate addition of the phenol at the beginning of this route had given a cis 
orientation between the phloroglucinol-derived ring and the carbonyl, and this orientation 
may be the reason why the electrophilic aromatic substitution onto the carbonyl is the 








Figure 2.3.1 Possible orientation of aromatic over the carbonyl 
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 The problems associated with the cyclization in this series of dienones were not 
overcome, so attention turned toward the formation of the benzofuran ring prior to the 
cyclization event.  Incorporation of the benzofuran olefin into the dienone system could 
avoid the issues faced with the undesired cyclization. 
 
2.4 Benzofuran Dienone Strategy 
 It was supposed that incorporating the unsaturation of a fully formed benzofuran 
ring into the dienone system might yield a substrate that could react in a more predictable 
manner toward a Nazarov cyclization.  If an efficient route to a dienone such as 2.4.1 
could be found, formation of the C-ring of rocaglamide under Lewis acidic conditions 
might readily occur (Scheme 2.4.1).  Moreover, this strategy could be advantageous since 
cyclization and trapping of the allylic cation with a nucleophile, such as a halide or water, 






































Scheme 2.4.1 Proposed Nazarov cyclization   
 
Trapping of the Nazarov intermediate with nucleophiles is well documented.38-44  
Of particular interest, was a report by West on halide trapping of the Nazarov 
intermediates in strained polycyclic systems.45  He found that treatment of bicyclic 
dienones such as 2.4.5 with TiCl4 resulted in cyclization and trapping of the intermediate 
oxoallylic cation by a chloride anion giving 2.4.6 (Scheme 2.4.2).  In contrast to the usual 
elimination pathway, which destroys a stereocenter formed during the electrocyclization, 
this trapping event preserved both of the newly formed stereocenters.  In addition, the 








      TiCl4 (1 equiv.)
CH2Cl2, -78 
oC to 0 oC






(single stereoisomer)  
Scheme 2.4.2 Halide trapping of the Nazarov intermediate  
 
 With this in mind, creating routes to the required dienones began the 
cyclization/nucleophile trapping strategy in relation to the total synthesis of rocaglamide.       
 
2.4.1 Formation of the Benzofuran Ring 
 In order to gain access to the dienones that were desired, a good route to the 
benzofuran ring system was needed.  A few different routes were devised that could grant 
access to various benzofuran ring systems.  Synthetic routes to three benzofuran systems 
in particular were the focus of this work (Figure 2.4.1).  It was thought that these 
scaffolds would provide a good starting point toward the synthesis of a variety of 

















Figure 2.4.1 Desired benzofurans 
  
 A route to benzofuran 2.4.1, containing a ketone at the 3-position, was first laid 
out.  This benzofuran could give access to dienones via aldol condensation with 
benzaldehyde. 
 Published reports for this type of compound relied on a Baeyer-Villiger-type 
reaction of 3-alkylflavylium salts to form the benzofuran products.46-48  Mechanistically, 
the addition of hydrogen peroxide to flavylium salt 2.4.4 is followed by migration of the 
vinyl group to give carbonium ion 2.4.5 (Scheme 2.4.1).   Trapping of the carbonium ion 
by methanol furnishes compound 2.4.6.  Opening of the 7-membered heterocycle, then 











































Scheme 2.4.1 Baeyer-Villiger oxidation of 3-alkylflavylium salts 
 
The strategy began with a Vilsmeier-Haack formylation of 1,3,5-
trimethoxybenzene to obtain aldehyde 2.4.8 in quantitative yield  (Scheme 2.4.2).  















  POCl3, DMF
1,2-DCE, 50 oC
       100%
          BCl3
CH2Cl2, 0 
oC to r.t.
          100%
 
Scheme 2.4.2 Formation of phenolic aldehyde for flavylium salt formation     
 
 The formation of the benzofuran was accomplished in two more steps.  Formation 
of the flavylium salt 2.4.11 with dry HCl and 4′-methoxypropiophenone in EtOAc, 
followed by oxidation with hydrogen peroxide in MeOH and 4N HCl gave ketone 2.4.1 
























   MeOH, r.t.
15% (2 steps)
 
Scheme 2.4.3 Synthesis of benzofuran ketone 
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A number of conditions were screened for this two-step transformation, but the 
yield of 2.4.1 could not be improved.  Although the desired ketone was available by this 
route, the low yield associated with the oxidation was not going to be practical for 
bringing through the large amounts of material needed to advance the synthesis.  
Therefore, the focus shifted toward making the two other benzofuran substrates. 
 The 3-protio benzofuran 2.4.2 was imagined coming from a Lewis acid promoted 
demethylation and cyclization.  Benzofuran 2.4.2 could grant access to dienones by a 
Friedel-Crafts acylation at the 3-position of the benzofuran.  Alternatively, lithiation of 
the 3-position followed by acylation could be carried out to obtain the desired dienones.  
Benzofuran 2.4.2 was available in 3 steps from 1,3,5-trimethoxybenzene (Scheme 
2.4.4.).  Iodination of 1,3,5-trimethoxybenzene was carried out with 0.5 equivalents of 
iodine and hydrogen peroxide to give a quantitative yield of iodinated arene 2.4.12.50  
Palladium-catalyzed α-arylation51 of 4′-methoxyacetophenone with iodo-arene 2.4.12 
yielded ketone 2.4.13 in 81% yield.  The use of tricyclohexylphosphine as the ligand on 
palladium gave better yields than other phosphine ligands screened (PPh3, P(NMe2)3).  
Comparable yields of 2.4.13 could also be obtained using Pd(PtBu3)2 as the source of 
palladium(0).  Finally, formation of benzofuran 2.4.2 proceeded via demethylation, 
cyclization and dehydration using BCl3 in CH2Cl2.  This route to benzofuran 2.4.2 was 
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Scheme 2.4.4 Formation of 3-protio-benzofuran 
 
Access to the benzo[b]furan-3-carboxylate 2.4.3 was also desired.  This 
compound could provide dienones via Horner-Wadsworth-Emmons olefination.  The 
ester was imagined coming from a Pd(II)-catalyzed carbonylative cyclization of phenolic 
acetylene 2.4.14 which, in turn, could be synthesized by Kumada coupling of iodophenol 





















Scheme 2.4.5 Route to benzofuran with methyl ester at 3-position 
 
 The synthesis of 2.4.3 began with the iodination of 3,5-dimethoxyphenol.  There 
are many reported procedures for iodination of activated arenes.  A protocol was needed 
that would give a good ratio of ortho to para iodination and would be scalable, since 
large amounts of this starting material would be needed. 
 A variety of conditions for the iodination were screened (I2/Cu(OAc)2,53 I2/HgO,54 
I2/Fe(NO3)3/H3PW12O40,55 HIO4/Al2O3,56 I2/CAN,57 I2/SiO2/Fe(NO3)3,58 I2/morpholine,59  
NH4I/Oxone,60 ICl/NaHCO361).  However, they either gave a poor ratio of ortho to para 
iodination or significant amounts of diiodination.  While the I2/HgO protocol gave a fair 
ratio and yield, the results were not always reproducible, and it required a stoichiometric 
amount of mercury.   
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 Eventually a procedure reported by Stavber et. al.62,63 was used.  It required 0.5 
equivalents of iodine with 0.65 equivalents of hydrogen peroxide in a mixture of 
acetonitrile and water (Equation 2.4.1).  This procedure gave a 7:3 ratio of ortho to para 
iodination in 97% combined yield on scales of up to 50 grams.  The two major products 
could be separated by column chromatography.  Small amounts of diiodo compound 
could be removed by recrystallization from 20% EtOAc in hexanes to yield pure 2-iodo-















  I2, H2O2
MeCN/H2O
       r.t.
+ +
2.4.16 2.4.17
65% 32% 3%  
Equation 2.4.1 Iodination of 3,5-dimethoxyphenol   
 
The undesired para isomer could also be recycled under acidic conditions to give 
larger amounts of the ortho-iodo compound.  Treatment of para-iodo compound 2.4.16 
with 1N HCl in acetonitrile gave a 7:3 ratio of ortho-iodo phenol 2.4.15 to para-iodo 
phenol 2.4.16 (Scheme 2.4.6).  This transformation occurs through an ipso protonation of 
2.4.16, followed by cleavage of the carbon-iodide bond, giving ICl.  The ICl can then 
iodinate the aromatic ring again, giving the two products.  Acetonitrile was necessary as 
the solvent, because methanol caused the formation the diiodo compound and 3,5-






























Scheme 2.4.6 Ipso-protonation/iodination mechanism 
 
With a reproducible route to significant quantities of iodophenol 2.4.15, the 
Kumada64 cross-coupling, using conditions52 worked out by Dr. Trevor Rainey, furnished 













       then
Pd(PPh3)2Cl2
      65 oC
      82%  
Equation 2.4.1 Kumada cross coupling 
 
 73 
Palladium(II)-catalyzed carbonylative cyclizations are well-precedented.65-68  
Treatment of phenolic acetylenes such as 2.4.14 with a palladium(II) source, a base and 
an oxidant in an alcoholic solvent under a CO atmosphere gives rise to carbonylated 
benzofurans.  
The mechanism involves coordination of palladium(II) to acetylene 2.4.17 
followed by attack of the phenolic oxygen to generate benzofuryl palladium complex 
2.4.18 (Scheme 2.4.7).  Insertion of carbon monoxide into the carbon-palladium bond 
generates acylpalladium species 2.4.19.  Attack of methanol on the acylpalladium species 
followed by reductive elimination with the loss of HX from palladium yields a Pd(0) 






























Scheme 2.4.7 Palladium-catalyzed carbonylative cyclization    
 
 A screening of conditions (Table 2.4.1) began for the transformation of 2.4.14 
into 2.4.3 (Equation 2.4.2).  The 3-protio benzofuran 2.4.2 was isolated as a major by-
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Equation 2.4.2 Palladium-catalyzed carbonylative cyclization 
 
Pd(II) source Oxidant Base Yield 2.4.3 Yield 2.4.2 
Pd(OAc)2 CuCl2 NaOAc 32% 9% 
Pd(OAc)2 CuCl2 K2CO3/NaOAc 23% 49% 
Pd(OAc)2 CuI/O2 NaOAc 51% 24% 
Pd(OAc)2 CuI/O2 CsOAc 44% 29% 
Pd(PPh3)2Cl2 CuI/O2 K2CO3 25% 60% 
PdCl2 CBr4 NaOAc 66% 25% 
Table 2.4.1 Conditions for carbonylative cyclization 
 
 It was clear from an extensive screening of conditions that cyclization to 
benzofuran 2.4.2 was problematic.  2-Alkynylphenols such as 2.4.14 are known to 
autocyclize,66 and it was observed that if 2.4.14 was not stored in the freezer, it would 
slowly cyclize to benzofuran 2.4.2.  It was noted that stronger bases, such as potassium 
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carbonate, gave lower yields of the carbonylated product, and greater quantities of 2.4.2 
presumably by cyclization of the phenolate.  However, with weaker bases (NaOAc, 
CsOAc), it was believed that proto-depalladation to 2.4.2 was occurring since acetic acid 
was being formed in the reaction.    
The testing of various oxidants for palladium(0) revealed that carbon tetrabromide 
was a superior oxidant to any copper source.  Carbon tetrabromide was chosen because 
Yang had previously reported that it functioned well as an oxidant for Pd(0).68   
The best conditions that could be extracted from the literature were using a 
system of CBr4 and NaOAc.  However, this procedure only worked well on scales of 
about 100 milligrams or less.  When using scales larger than 100 milligrams, the yield of 
2.4.3 dropped dramatically and the 3-protio benzofuran became the major product. 
A better procedure to reduce the amount of 2.4.2 formed and increase 2.4.3 was 
required.  It was known at this point that complete deprotonation with a strong base gave 
a lot of autocyclization, and weaker bases generated acid (AcOH), leading to proto-
depalladation.  Therefore, it seemed reasonable to try sodium bicarbonate as the base in 
the reaction.  This base would not fully deprotonate the phenol and would only generate 
water and carbon dioxide upon proton abstraction, thus possibly reducing the formation 
of 2.4.2.   
It was exciting to find that the combination of NaHCO3 as the base and CBr4 as 
the oxidant provided a 75% yield of the carbonylated product 2.4.3, with less than 5% of 
the undesired product 2.4.2 (Equation 2.4.3).  This protocol was reproducible on a 3-gram 
scale.  It is also noteworthy that while typical conditions required loadings of 5-10 mol% 
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palladium, the transformation under these optimized conditions required only 2 mol% 
palladium.  To our knowledge, this is the first time sodium bicarbonate has been 














 Pd(OAc)2, CO (1 atm) 
      CBr4, NaHCO3
         MeOH, r.t.










Equation 2.4.3 Optimized conditions using NaHCO3     
 
 Finally, to reduce some steps in the synthesis, a direct conversion of 2.4.14 into 
dienone 2.4.21 was attempted.69,70  The transformation employing palladium catalysis, 






















Equation 2.4.4 Attempted formation of dienone 
 
 With high yielding and scalable routes to two benzofurans, the advancement of 
these compounds to dienones for the Nazarov cyclization was studied.   
 
2.4.2 α-Cyano Dienone 
 Initial studies focused on the cyclization of dienone 2.4.22, which contains a 
cyano group at the alpha position.  The torquoselectivity of the cyclization should be 
affected by having the electron-withdrawing group in the α-position, possibly allowing 
for trapping of the benzylic cation with a nucleophile (Scheme 2.4.8).  Nazarov 
cyclizations of heteroaromatics are known to proceed cleanly when the dienone is 
polarized.71,72  However, an interrupted Nazarov reaction occurring with heteroaromatics 


































Scheme 2.4.8 Interrupted Nazarov reaction of α-cyano dienone 
 
 The synthesis of dienone 2.4.22 started with formation of the α-cyano ketone by 
addition of lithiated acetonitrile to ester 2.4.3 (Scheme 2.4.9).  Dienone 2.4.22 was then 
formed using a Knoevenagel condensation with benzaldehyde.  The product was obtained 
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Scheme 2.4.9 Formation of α-cyano dienone 
 
 Dienone 2.4.22 was resistant to cyclization under a variety of conditions.  While 
weak Lewis acids, such as Cu(OTf)2, returned unreacted starting material, harsher 
conditions only resulted in intractable mixtures. The screening of a number of Lewis 
acids (TiCl4, Sc(OTf)3, SnCl4, FeCl3) and protic acids (H2SO4, HCl), all resulted in 
decomposition of the starting material.   
 During the course of our work on the rocaglamides, Alison Frontier at the 
University of Rochester had been in contact with us about her work on the rocaglamides.  
Her group had also been working on a synthesis of rocaglamide using a Nazarov strategy.  
They had synthesized dienone 2.4.27, a similar substrate to α-cyano dienone 2.4.22, 













Figure 2.4.2 Frontier’s polarized dienone 
 
Since an electron-withdrawing group at the α-position of the dienone was not 
helping to promote the cyclization, a new approach needed to be taken.  In previous work 
from the Magnus group, Dr. Matt Stent observed that cyclization to the C-ring readily 
occurred when an electron-donating substituent occupied the 2-position of the 
pentadienyl cation (see Scheme 1.5.3).74  This information suggested that the electron-
withdrawing group at this position might be hindering the cyclization.  Therefore, this α-
cyano strategy was discontinued to focus on some substrates that might be better set up 
for cyclization to the C-ring of rocaglamide. 
 
2.4.3 α-Protio Dienone  
 Dienone 2.4.21 should be readily accessed from the previously synthesized 
benzofurans.  This compound replaced the electron-withdrawing cyano group with a 
proton, thus decreasing the polarization of the dienone compared to 2.4.22.  It was 
thought that this substrate might be better suited for cyclization under Nazarov 
conditions.   
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The most direct path to dienone 2.4.21 was via Friedel-Crafts acylation of 2.4.2 
with cinnamoyl chloride (Equation 2.4.5).  Upon treatment of cinnamoyl chloride with a 
Lewis acid in the presence of benzofuran 2.4.2, the expectation was that acylation would 


















Equation 2.4.5 Friedel-Crafts acylation to synthesize α-protio dienone 
 
 While dienone 2.4.21 was formed in small amounts using SnCl4 at -78 oC, the 
major product arose from acylation at C-7 of the benzofuran, yielding 2.4.28 and 2.4.21 






























Equation 2.4.6 Friedel-Crafts acylation with cinnamoyl chloride 
 
 After extensive screening of solvents (CH2Cl2, nitrobenzene, toluene), Lewis 
acids (TiCl4, SnCl4, AlCl3, ZnCl2) and reaction temperatures, the best ratio of dienone 
2.4.21 to C-7 acylated compound 2.4.28 was 1:1.5 using TiCl4 in CH2Cl2 at room 
temperature.  More reactive acylium ions, such as that derived from acetyl chloride, only 
generated the product of acylation at C-7.   
The inclination for electrophiles to react predominantly at the undesired position 
caused the focus of the research to shift away from the Friedel-Crafts strategy.  Lithiation 
of the benzofuran at the 3-position was also attempted.  Upon lithiation of 2.4.2 with 
LDA or n-BuLi, opening of the benzofuran ring occurred to give phenolic acetylene 
2.4.14, and no trapping of electrophiles was obtained.  Therefore, a Horner-Wadsworth-
Emmons olefination approach to dienone 2.4.21 was used.  
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Methyl ester 2.4.3 reacted with lithiated dimethyl methylphosphonate providing 
β-keto phosphonate 2.4.29 in 89% yield (Scheme 2.4.10).  Horner-Wadsworth-Emmons 
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Scheme 2.4.10 Synthesis of α-protio dienone 
 
The Nazarov cyclization of dienone 2.4.21 could now be examined.  There were 
two possible outcomes from the cyclization that were considered (Equation 2.4.7). The 
first was that cyclization could be followed by trapping of the allylic cation at the 
benzylic position to obtain cyclopentanone 2.4.30, an intermediate in Taylor’s synthesis 
of rocaglamide.  Secondly, a proton abstraction adjacent to the phenyl could yield 



























Equation 2.4.7 Desired Nazarov cyclization 
  
 The cyclization was attempted under a variety of conditions (Table 2.4.2).75  
Unfortunately, no cyclized products were ever formed.  Lewis or protic acids only 
returned starting material at room temperature, but upon heating the reaction mixtures, a 
retro Friedel-Crafts reaction would ensue giving the parent benzofuran 2.4.2 and 










Reagents and Conditions Results 
AlCl3, 1,2-DCE, 50 oC Retro Friedel-Crafts 
Cu(OTf)2, 1,2-DCE, 120 oC No reaction 
Sc(OTf)3, 1,2-DCE, 50 oC Retro Friedel-Crafts 
conc. H2SO4, dioxane, 100 oC Retro Friedel-Crafts 
conc. HCl, dioxane, 100 oC No reaction 
TiCl4, CH2Cl2, r.t. Demethylation 
conc. HCl, AcOH, 100 oC Retro Friedel-Crafts 
Table 2.4.2 Reaction conditions for Nazarov cyclization 
 
 The retro Friedel-Crafts reaction proceeded by protonation of the 3-position of the 
benzofuran, forming oxonium species 2.4.32 (Scheme 2.4.11).  Fragmentation via 
acylium ion formation and quenching of the oxonium ion yields benzofuran 2.4.2 and 



































Scheme 2.4.11 The retro Friedel-Crafts fragmentation 
 
It was interesting to observe that concentrated HCl in dioxane at elevated 
temperatures returned the starting material, as opposed to the retro Friedel-Crafts reaction 
seen with H2SO4 in dioxane and HCl in AcOH.  This is important to note, as it will 
become useful toward understanding future results. 
Formation of a delocalized cation was apparent under the reaction conditions 
since a color change to dark purple would accompany the addition of acid into the 
reaction mixture.  If the cationic cyclization were taking place to a small extent, but just 
reversing, it might be possible to trap the allylic cation of the cyclized product with an 
appropriate hydride source.  This type of reaction is termed a reductive Nazarov 
reaction.76,77  With this in mind, dienone 2.4.21 was treated with BF3•OEt2 and 
triethylsilane in dichloromethane as reported in the literature (Equation 2.4.8).  The hope 
was to isolate cyclopentanone 2.4.33 from the reaction mixture, but a quantitative yield of 




























Equation 2.4.8 Attempted Reductive Nazarov 
 
In the case of dienone 2.4.21, it was believed that the equilibrium of the 
pentadienyl cation and allylic cation may lie towards the former because of the electron-
donating effect of the β-oxygen.  Theoretical calculations predict the retro Nazarov 
reaction to be highly exothermic when an alkoxy group occupies the β-position of the 
dienone, and experiments support this prediction.78,79  Thus, it was hypothesized that by 
providing increased stabilization of the allylic cation through more substitution at the α-
position, the cyclization may occur more readily.  Trapping of the allylic cation or proton 
loss to an alkene would drive the reaction to completion by providing a thermodynamic 
sink.  The feasibility of this hypothesis could be tested by incorporation of a methyl 




2.4.4 α-Methyl Dienone 
 The synthesis of the α-methyl dienone proceeded by reaction of ester 2.4.3 with 
lithiated diethyl ethylphosphonate to give β-ketophosphonate 2.4.35 (Scheme 2.4.12).  
Horner-Wadsworth-Emmons olefination using Masamune-Roush conditions80 yielded 















     n-BuLi
 EtP(O)(OEt)2
   then 2.4.3
  THF, -78 oC
        90%
       
    PhCHO 
  DBU, LiCl
toluene, reflux










Scheme 2.4.12 Formation of α-methyl dienone 
 
 Nazarov cyclizations leading to α-methylenecyclopentanones are known,81,82 and 
it was possible that treatment of 2.4.36 with a Lewis acid could trigger the cyclization 
and loss of a proton to 2.437 (Equation 2.4.9).  If 2.4.37 were obtained, the oxidation of 
the exo-methylene and advancement of this compound to rocaglamide should be 
straightforward.  There was also the possibility that proton loss may take place next to the 
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Equation 2.4.9 Nazarov cyclization of 2.4.36     
 
 The screening of conditions began to determine if the incorporation of a methyl at 
the α-position of the dienone would increase the propensity toward cyclization.  Heating 
2.4.36 with a variety of Lewis acids (SnCl4, AlCl3, Sc(OTf)3, etc.) only caused 
fragmentation of the molecule in a retro Friedel-Crafts fashion.  This was disappointing, 
as this problem had been encountered with the α-protio dienone as well.  However, upon 
treatment with concentrated HCl in dioxane at 100 oC for 48 hours,83 a new compound 
had formed.  Upon purification of the reaction mixture, cyclopentenone 2.4.38 was 
isolated in 12% yield, along with a large amount of unreacted and decomposed materials 
(Equation 2.4.10).  The structure of 2.4.38 was confirmed by X-ray crystallography (See 
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Appendix 2).  This result proved our hypothesis that adding a methyl substituent at the α-

















    conc. HCl
dioxane, 100 oC
     48 hours
        12%  
 
Equation 2.4.10 Successful cyclization   
 
 The double bond ended up endocyclic meaning that the C-3 stereocenter formed 
during the cyclization was destroyed.  Though not ideal, this result should not be 
problematic since Trost had reported a selective reduction of a cyclopentenone to the cis 
diaryl configuration in his synthesis of rocaglamide.  We were also confident that 
oxidation of the methyl to the dimethyl amide could be achieved on this substrate by 
allylic oxidation.  Therefore, optimization of the reaction conditions was investigated to 
improve the yield and decrease the reaction time. 
The crude reaction mixture had a lot of decomposed material in the NMR 
spectrum.  It was believed that this decomposition might have resulted from two possible 
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reactions.  First, some could arise from the opening of dioxane by HCl under the reaction 
conditions.  Also, once the product 2.4.38 was observed by TLC, the reaction mixture 
turned a dark crimson color.  This color change may have been indicative of the opening 
of the furan ring to form a triarylcyclone (Figure 2.4.3).  Triarylcyclones are known to 
turn a solution dark crimson and they are quite reactive.84  It was believed that this 
triarylcyclone might be decomposing under the strongly acidic conditions.  These side 
reactions needed to be avoided in order to improve the yield and decrease the reaction 









Figure 2.4.3 Triarylcyclone  
 
It was thought that using milder conditions to induce the cyclization could lessen 
the side reactions.  Therefore, the dienone was treated with a more dilute solution of HCl 
(6M) in dioxane.  However, this made the reaction proceed even slower and did not 
improve the yield. 
Other conditions employing concentrated HCl were examined to improve the 
efficiency of the reaction.  When acetic acid was used as the solvent, a small amount of 
cyclopentenone 2.4.38 was produced, but the major product arose from a retro Friedel-
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Crafts reaction.  Running the reaction in 1,2-DCE only caused the retro Friedel-Crafts 
fragmentation.  
Interestingly, the use of varying concentrations of H2SO4 in dioxane only gave the 
fragmentation products of the parent benzofuran and α-methylcinnamic acid.   
This led to the supposition that the chloride counterion from HCl might have been 
playing a role in promoting the cyclization, possibly by trapping the allylic cation 
intermediate and subsequently getting eliminated.  Thus, it was reasoned that adding 
chloride to the reaction mixture might be beneficial.  The addition of 5-10 equivalents of 
LiCl to the mixture of conc. HCl in dioxane, however, did nothing to shorten the reaction 
time or improve the yield. 
At this point, a deeper understanding about what was occurring in this reaction 
was needed.  The known facts were that the best results came using conc. HCl in dioxane 
as solvent.  Other solvents and acids were not as efficient or caused the fragmentation to 
take place.  We hypothesized that dioxane, being a participating solvent, may be playing 
a role in stabilizing some of the intermediates involved in the cyclization.  Furthermore, 
the chloride counterion may be necessary to prevent the retro Friedel-Crafts reaction by 
making the protonation at C-3 of the benzofuran reversible (Scheme 2.4.13).  This 
hypothesis might also support why no reaction was observed in the case of the α-protio 
dienone, since dioxane could stabilize the oxonium species formed upon carbonyl 
protonation and the chloride counterion prevented the retro Friedel-Crafts from occurring 










































































Scheme 2.4.13 Nazarov cyclization hypothesis   
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The hypothesis that dioxane was providing intermolecular stabilization of the 
Nazarov intermediates led the idea of using intramolecular stabilization of the oxyallyl 
intermediate to further improve the effectiveness of the cyclization.  Consequently, 
acylation of the carbonyl as a means of inducing the cyclization was explored.  Although 
Ac2O had been screened in the past with no positive results,52 it was believed that a more 
reactive acylating agent might be necessary to achieve the cyclization. 
 Acetyl bromide was chosen as the acylating reagent since it is very reactive and 
contains a good leaving group in Br-.  It was assumed that a more stable leaving group 
would make the acylation of the carbonyl less reversible.  This notion was proven correct 
when, upon treatment with AcBr in 1,2-DCE at 60 oC for 6 hours, cyclopentenone 2.4.38 
was isolated in 64% yield (Equation 2.4.11). Not only did these conditions improve the 
yield 5-fold, but they also significantly reduced the reaction time and lowered the energy 

















        AcBr
1,2- DCE, 60 oC
        6 hrs
        64%  
Equation 2.4.11 Nazarov cyclization using acetyl bromide    
 
Acetyl chloride was also tested for the cyclization.  However, only starting 
material was recovered after heating to 150 oC in a sealed tube.  This result was 
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rationalized by comparing the relative stabilities of the leaving groups.  Since bromide is 
a more stable leaving group than chloride, it was believed that the use of an acid bromide 
renders the acylation less reversible than with acid chlorides.85  To the best of our 
knowledge, this is the first time an acid bromide has been used to initiate a Nazarov 
cyclization.     
Based on these results, it was proposed that the reaction proceeded by acylation of 
the carbonyl followed by cyclization to the allylic cation (Scheme 2.4.14).  Stabilization 
of the cation by neighboring group participation of the acetate followed by proton loss 
gave the enol acetate.  Proton loss could either occur from the methyl, forming the exo-
methylene, which isomerized to the internal alkene with acid, or by direct loss of the 
proton adjacent to the phenyl.  Hydrolysis of the enol acetate on aqueous work-up 
provided cyclopentenone 2.4.38. 

















































Scheme 2.4.14 Mechanism of cyclization by acylation 
 
Even though this cyclization has been referred to as a Nazarov cyclization, there 
is no way of determining if it was indeed a stereospecific conrotatory electrocyclization 
since the stereochemistry at C-3 was lost.  It was possible that the reaction may have been 
either a cationic Prins-type cyclization or a Nazarov cyclization.  Either way, a good yield 
of 2.4.38 was obtained and the advancement toward rocaglamide could be continued.    
The installation of the benzylic hydroxyl and oxidation of the methyl group to a 
dimethyl amide needed to be addressed to complete the total synthesis. The allylic 
oxidation of the methyl substituent was examined first.   
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Many conditions were screened to oxidize the methyl group, but no methyl 
oxidation products were ever observed (Table 2.4.3).  Selenium dioxide and Pd(II) 
oxidations86 returned starting material.  Chromium trioxide/3,5-dimethylpyrazole87 and 
DDQ destroyed the molecule, while allylic bromination conditions resulted in multiple 
halogenations of the aromatics.  It was surprising that singlet oxygen gave no reaction as 
Foote had previously reported the oxidation of exo-methyl groups on cyclopentenones 
using those conditions.88   
 
Reagents and Conditions Results 
SeO2, dioxane or DCE, heat No reaction 
SeO2/t-BuOOH, DCE, heat No reaction 
Pd(II)/t-BuOOH, DCE, heat No reaction 
CrO3/3,5-dimethylpyrazole, CH2Cl2, 0 oC Decomposition 
DDQ, CH2Cl2, r.t. Intractable mixture 
NBS, benzoyl peroxide or AIBN, CCl4, 
reflux 
Aromatic halogenation 
1O2, various sensitizers No reaction 
Table 2.4.3 Some allylic oxidation conditions screened 
 
The installation of the tertiary hydroxyl was also being examined.  Ammonium 
cerium(IV) nitrate (CAN) in a 1:1 mixture of acetonitrile and water was found to 
selectively oxidize the benzylic position in excellent yield (Equation 2.4.12).89  This 
 99 
compound was also confirmed by X-ray crystallography (See Appendix 3), since the 
phenyl group strangely came as a singlet in the 1H NMR spectrum.  It was remarkable 
that oxidation of the benzylic position took precedent over oxidation of the extremely 


















     CAN
CH3CN/H2O
        r.t.
      88%
 
Equation 2.4.12 Oxidation of the benzylic position 
 
 With the benzylic hydroxyl in place, oxidation of the methyl was again 
investigated.  Sadly, none of the conditions screened, including those in Table 2.4.3, gave 
any of the desired oxidation product.  A less direct route to the oxidation though epoxide 
opening was envisioned as well, but attempts at epoxidizing the enone under basic 



















    MeOH, r.t.
X O
 
Equation 2.4.13 Epoxidation of the enone 
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 Since the oxidation of the methyl had proven to be more difficult than anticipated, 
we decided to reduce the ketone to the trans diol, as this is the required stereochemistry 
for rocaglamide.  Additionally, the reduction should render the double bond more 
electron-rich, making it more reactive toward allylic oxidation. 
 While reduction with DIBAL or LAH gave mixtures of cis and trans diols, 
NaBH4 gave a quantitative yield of the trans diol 2.4.41 (Equation 2.4.14).  The 
stereochemistry was determined by X-ray crystallography (See Appendix 4). The 
reduction most likely proceeded by templation of the NaBH4 to the tertiary alcohol 




















   100%
 
Equation 2.4.14 Reduction to trans diol 
 
 When the diol was treated with SeO2 in dichloromethane, the hope was that 
oxidation of the methyl substituent would take place.  The oxidation, however, occurred 




















    SeO2
CH2Cl2, r.t.
 
Equation 2.4.15 Oxidation of trans diol 
 
It was reasoned that oxidation of the methyl over the internal oxidation could be 
obtained if the secondary alcohol were transformed into an acetate.  The acylation should 
change the electronics of the system by pulling electron density from the internal 
hydrogen, thus making it less labile.  In turn, this might bias the oxidation unto the 
external methyl.   
 Treatment of diol 2.4.41 with acetic anhydride and catalytic DMAP gave the 
secondary acetate 2.4.42 in quantitative yield (Equation 2.4.16). Again, all efforts to 





















    100%
 
Equation 2.4.16 Formation of acetate 
  
The inability to oxidize the exo-methyl after the successful cyclization was 
disappointing.  However, since acetyl bromide was found to promote the cyclization of 
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the α-methyl dienone 2.4.36, it was crucial to try these new reactions conditions on the 
α-protio compound 2.4.21.  If the cyclization were to be successful with 2.4.21, the 
troublesome oxidation of the methyl substituent could be avoided.  Therefore, the α-
protio dienone was revisited.     
  
2.4.5 Revisiting the α-Protio Dienone 
 The cyclization of 2.4.21 was envisioned taking place under similar conditions as 
the α-methyl dienone to give cyclopentenone 2.4.31 (Scheme 2.4.15).  Benzylic 
oxidation could then be achieved using CAN, as this had worked well on the previous 
substrate.  Reduction of the double bond could give 2.4.44, an intermediate in Taylor’s 



































Scheme 2.4.15 Proposed route to Taylor’s intermediate   
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 Treatment of dienone 2.4.21 with AcBr in 1,2-DCE at 60 oC, the conditions used 
to cyclize the α-methyl dienone, gave no reaction.  However, once the temperature was 
increased to 100 oC, the starting material was consumed and two products were isolated 
(Equation 2.4.17).  Cyclopentenone 2.4.31 was produced in 12% yield along with 
dienone 2.4.45, a product derived from a demethylation and acylation of one of the 


























12% 67%  
Equation 2.4.17 Cyclization of α-protio dienone 
 
 It was apparent that the HBr generated during the course of the reaction was 
causing the demethylation to occur.  HBr is a classical reagent for demethylation of 
aromatic methoxyls.  The demethylated/acylated product’s structure was assigned as 
2.4.45 for it was assumed that a proton transfer occurred from the carbonyl to the nearest 
methoxyl on the A-ring to cause the demethylation.  
 The formation of 2.4.45 was not seen as problematic if the cyclization of this 
compound could still be induced. If the cyclization of 2.4.45 happened, the product 
2.4.46 could be deacylated and remethylated to give 2.4.31.  However, treatment of 
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2.4.45 with acetyl bromide in a sealed tube up to 150 oC only returned starting material 
















          AcBr
        1,2-DCE
150 oC, sealed tube
X
 
Equation 2.4.18 Failed cyclization of 2.4.45 
 
 This result implied that an extremely electron-rich A-ring might be necessary for 
stabilization of the allylic cation formed upon cyclization, since the phenolic acetate 
2.4.45 would not cyclize.  It also suggested that demethylation of the aromatic methoxyls 
by HBr would need to be prevented in order to improve the reaction. 
 Since no demethylation was observed in the α-methyl series at the 60 oC required 
for cyclization, it was believed that it might be possible to prevent the demethylation by 
lowering the temperature required for the cyclization of α-protio compound 2.4.21.  One 
way to do that could involve the use of an acid bromide capable of stabilizing the cationic 
intermediates to a greater extent.  Therefore, benzoyl bromide was studied for the 
cyclization, as the benzene ring should stabilize a cation to a greater extent than the 
methyl of acetyl bromide.   
The cyclization did indeed occur at a lower bath temperature of 75 oC with 


























10-15% ~60%  
Equation 2.4.19 Cyclization using benzoyl bromide 
 
 To avoid the demethylation, HBr needed to be destroyed as it was formed in the 
reaction.  Inorganic bases. such as K2CO3 or Al2O3, proved to be poor HBr scavengers.  
The hindered organic base 4-methyl-2,6-di-tert-butylpyridine destroyed the acid bromide, 
stalling the reaction.   
Scavenging HBr with double bonds was also considered.  Cyclohexene was tried 
first and determined to be inefficient as a scavenger.  Limonene had been used as an HCl 
scavenger by others with good results,91 so it was examined in this reaction.  When the 
dienone was reacted with benzoyl bromide and limonene, no demethylation was 
observed.  However, the yield of 2.4.31 remained around 20% (Equation 2.4.20).  
Although the starting material had been completely consumed, a large amount of material 


















   BzBr
limonene
   DCE




Equation 2.4.20 Scavenging HBr with limonene 
 
 A number of conditions were changed in an effort to improve the reaction.  
Changing the acid bromide to p-nitrobenzoyl bromide or p-methoxybenzoyl bromide 
failed to improve the yield.  The addition of Lewis acids (AlCl3, AlBr3) along with the 
acid bromides did not increase the yield either.  Solvent changes from 1,2-dichloroethane 
(PhNO2, PhCl, toluene, cyclohexane) also provided no better results.  An increase in 
temperature to 120-140 oC in chlorobenzene or nitrobenzene was also met with limited 
success. 
 Other noteworthy conditions that failed to produce the product are the use of acyl 
triflate 2.4.47, mixed anhydride 2.4.48, and full acylium ion 2.4.49 (Figure 2.4.4).  
Iminium catalysis was also investigated to induce the cyclization.  It was presumed that 
the carboxylate present on proline might stabilize the allylic cation upon cyclization.  
However, proline gave no reaction up to 150 oC, which is not surprising since nitrogen 












2.4.47 2.4.48 2.4.49  
Figure 2.4.4 Other reagents screened for cyclization 
 
 While optimization of the cyclization continued, the cyclized material that had 
been collected was advanced toward rocaglamide.  The oxidation of the benzylic position 
with ceric ammonium nitrate was a bit problematic on this substrate.  The yields of 2.4.50 
varied significantly from 0-50% (Equation 2.4.21).  The product seemed to be getting 
















        CAN
CH3CN/H2O, r.t.
       0-50%
 
Equation 2.4.21 Oxidation of the benzylic position 
 
 Although the yield of the oxidation was poor and not reproducible at this time, it 
was believed that it could be optimized later if the compound was useful.  It was critical 
to know if the reduction of the enone to the cis diaryl configuration could be achieved on 
this substrate.  Trost had published the reduction on a similar substrate in his synthesis of 
rocaglamide.   
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 Unfortunately, reactions using catalytic hydrogenation (Pd/C, Pd/BaSO4, PtO2, 
Pd(OH)2) were messy, and the crude reaction mixtures did not contain any of the desired 
cyclopentanone.  Copper hydride sources only gave recovered starting material and 
Et3SiH/BF3•OEt2 caused the reduction of the benzylic hydroxyl.  Taylor had synthesized 
2.4.50 during the course of his work on rocaglamide and he too was unable to reduce the 




















Equation 2.4.22 Reduction of enone 2.4.50    
 
 Reduction of cyclopentenone 2.4.31 was also unsuccessful under a number of 



















Equation 2.4.23 Reduction of enone 2.4.31 
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A revision of the strategy was again necessary to overcome the problems 
associated with this route, since the Nazarov cyclization of the α-protio dienone and 
subsequent transformations did not provide satisfactory results.    
  
2.4.6 α-Methoxymethyl Dienone 
 It was obvious that the cyclization was more efficient with substitution at the 
alpha position of the dienone, for it lowered the activation energy of the cyclization and 
provided more stable intermediates.  The inability to oxidize the methyl substituent after 
the cyclization occurred in the α-methyl series, however, put an end to that route.  
Therefore, it was decided that the methyl would be oxidized prior to the cyclization.  This 
should keep the reactivity of the dienone high, while possibly allowing for the double 
bond to end up exocyclic (Scheme 2.4.16).  If it did end up exocyclic, it was possible that 



























2.4.52 2.4.53 2.4.54  
Scheme 2.4.16 Cyclization of the oxidized α-substituent 
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 An allylic oxidation of 2.4.36 was first attempted to synthesize 2.4.52 (Equation 
2.4.24).  Unfortunately, all conditions screened, including SeO2, 1O2, and DDQ, failed to 




















Equation 2.4.24 Allylic oxidation of dienone 
 
 Baylis-Hillman chemistry was next explored to install the extra carbon.  
Treatment of dienone 2.4.21 with distilled gaseous formaldehyde and DABCO or PPh3 
only returned unreacted starting material (Equation 2.4.25).  It was thought that KOH 
might be a better promoter of the reaction but these conditions did not produce any 
product either.  The use of Et2AlI to promote the Baylis-Hillman reaction93 caused a retro 


















DABCO or PPh3 or KOH
               CH2O
 
Equation 2.4.25 Baylis-Hillman attempt 
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Methoxide had previously been shown to work well in Baylis-Hillman reactions 
giving good yields of allylic alcohols.94  So NaOMe was screened in this reaction.  It was 
believed that methoxide might be more reactive than amines or phosphines in the 1,4-
addition, which might increase the concentration of the enolate in solution, thus allowing 
more efficient trapping by formaldehyde.  When dienone 2.4.21 was treated with sodium 
methoxide and paraformaldehyde in THF, a quantitative yield of allylic methoxyl 
compound 2.4.53 was obtained (Equation 2.4.26).  This product came about by 
dehydration after trapping of the enolate by formaldehyde, followed by re-addition of 
methoxide to the double bond terminus.  Loss of one methoxide to give the more 


















       THF, r.t.
         100%
 
Equation 2.4.26 Baylis-Hillman reaction with methoxide     
 
 With the α-methoxymethyl dienone in hand, exploration into the Nazarov 
cyclization of this substrate was begun.  Treatment with Lewis acids again caused a retro 
Friedel-Crafts reaction, so attention turned to the previously discovered acid bromide 
promoted cyclization conditions.  Complete consumption of the starting material was 
observed when dienone 2.4.53 was treated with AcBr and cyclohexene in 1,2-DCE at 45 
 112 
oC.  However, the product obtained was allylic bromide 2.4.54 in 97% yield (Equation 
2.4.27).  It was presumed that cyclohexene was not a good enough scavenger of HBr, and 



















  1,2-DCE, 45 oC
            97%
 
Equation 2.4.27 Formation of allylic bromide 
 
 The bromomethyl dienone 2.4.54 was treated with AcBr at 65 oC to determine the 
products of cyclization.  It was observed that cyclization did occur, but the bromide was 
lost during the transformation.  The only product formed in the reaction was 


















        AcBr
1,2-DCE, 65 oC
 
Equation 2.4.28 Cyclization of α-bromomethyl dienone 
 
 The isolation of the internal alkene from cyclization of the α-bromomethyl 
dienone 2.4.54 showed that the exo-methylene could indeed isomerize to the more 
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substituted internal alkene under the reaction conditions.  It was unfortunate that the 
bromide was lost during the cyclization event since oxidation of the methyl substituent 
had proven to be extremely difficult.  
 After determining that the α-bromomethyl dienone was of no use, the cyclization 
of the α-methoxymethyl compound using a more efficient HBr scavenger was examined.  
Upon treatment of dienone 2.4.53 with AcBr and limonene at 65 oC, the formation of a 
single compound by TLC was observed.  However, the NMR spectrum showed a mixture 
of two compounds.  Based on the IR data, mass, and NMR spectrum, the two compounds 
were assigned as a mixture of the dienol acetates 2.4.55 and 2.4.56 (Equation 2.4.29). 
The mixture of compounds was very unstable and they rapidly degraded when left 
overnight on the bench.  The mixture was not stable to column chromatography either.  
Therefore, it was necessary use the crude material immediately after it was formed to 



























   AcBr
limonene
1,2-DCE
  65 oC
 
Equation 2.4.29 Nazarov cyclization of α-methoxymethyl dienone 
 
The stereochemistry at the C-3 carbon with the phenyl substituent was unclear 
and a stable compound that could be more easily identified was desired.  To achieve this, 
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epoxidation of the mixture was attempted.  Epoxidation and opening could introduce the 
tertiary alcohol present in rocaglamide.  Treatment of the mixture of acetates with up to 4 





















    r.t.
No reaction
 
Equation 2.4.30 Unsuccessful epoxidation   
 
 Next, it was thought that cleavage of the acetates might deliver a single stable 
compound that might be easier to identify.  Treatment with K2CO3 in methanol at room 
temperature gave a complex mixture of products.  When 2.4.55 and 2.4.56 were treated 
with 2N NaOH in dioxane at room temperature, a clean reaction ensued that again gave a 
mixture of two compounds.  The structures of the two compounds were once more 
unclear.  They were somewhat stable to column chromatography, but inseparable. The 
structures were originally assigned as 2.4.57 and 2.4.58 based on the collected data 
(Scheme 2.4.17). The treatment of 2.4.57 and 2.4.58 with acetic anhydride and 
triethylamine gave back the mixture of 2.4.55 and 2.4.56, so it was assumed that the 










































Scheme 2.4.17 Cleavage of the acetates            
 
 Since the enols 2.4.57 and 2.4.58 were more stable than the acetates, their 
conversion into a single crystalline compound was attempted.  The determination of the 
stereochemistry at the phenyl substituent was still of interest, as the cis orientation of the 
aromatics was desired.   
A number of transformations were tried (oxidations, reductions, functional group 
transformations) to reach a stable, crystalline compound.  All conditions screened always 
gave mixtures of at least two compounds.  When 2.4.55 and 2.4.56 were eventually 
treated with trimethylsilyldiazomethane, a single compound was obtained (Equation 
2.4.31).  The structure of the compound had been assigned as 2.4.59 because the small 
2.2 Hz meta coupling of the aromatic protons on the A-ring in the NMR spectrum seemed 





























   DIPEA
  CH3CN/
   MeOH
       r.t.  
Equation 2.4.31 Treatment with TMSCHN2   
 
 2.4.59 was crystallized and its structure determined by X-ray crystallography (See 
Appendix 5).  The X-ray crystal structure showed that the originally assigned structure of 
2.4.59 was incorrect.  The furan ring had been opened at some point during the 3-step 
transformation, and the actual structure is shown below (Figure 2.4.4).  The meta 
coupling observed in the NMR spectrum came from atropisomers.  The barrier to rotation 
about the C2-C6 bond must be slow enough that the two protons appear distinct by NMR 






MeO         
Figure 2.4.4 X-ray structure showing opened furan 
  
 After reexamining the data, it now made sense why at least two compounds had 
appeared in every transformation since the atropisomers were causing this effect.  
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Therefore, the structures were reassigned based on this new evidence.  It was determined 
that the opening of the furan ring had occurred during the initial cyclization step with 










   AcBr
limonene
1,2-DCE
































   TMSCHN2
      DIPEA
     CH3CN/
      MeOH
23% (3 steps)
2.4.55 2.4.56
2.4.57 2.4.582.4.59  
Scheme 2.4.18 Reactions and reassigned structures 
 
 With a grasp on the structures of the molecules, the closure benzofuran ring was 
examined.  Unfortunately, under acidic or basic conditions, 2.4.57 and 2.4.58 did not re-




2.4.7 α-Benzyl Dienone 
 While working with the α-methoxymethyl dienone, experiments were also 
ongoing with a benzyl group at the alpha position of the dienone.  Again the question was 






























Equation 2.4.32 Proposed cyclization products of α-benzyl dienone 
 
 The synthesis of dienone 2.4.60 was straightforward starting from previously 
synthesized ketone 2.4.34 via aldol condensation.  Treatment of the ketone with 




















    dioxane, r.t.
           50%
 
Equation 2.4.33 Synthesis of α-benzyl dienone 
  
 When treated with acetyl bromide in 1,2-DCE, the starting material was 
consumed and a mixture of two products was obtained (Equation 2.4.34).  Unfortunately, 
the products were again a mixture of atropisomers 2.4.63 and 2.4.64, which came about 










   AcBr
1,2-DCE
  50 oC













2.4.63 2.4.64  
Equation 2.4.34 Cyclization and opening of furan 
  
 The inability to prevent the benzofuran ring from opening when the double bond 
remained exocyclic was troubling and no conditions were found to overcome this 





 A number of routes to rocaglamide have been studied.  Successful construction of 
the tricyclic core was achieved using a novel acid bromide promoted cyclization of a 
dienone.  Unfortunately, conditions were never found to advance the late-stage 
intermediates to the natural product.  Oxidation of the methyl substituent proved to be 
more difficult than had been anticipated, and the lack of a substituent at the alpha position 
of the dienone failed to generate good yields in the cyclization.     
The propensity of the benzofuran to open when the double bond remained 
exocyclic was disappointing, as the stereochemistry achieved through the cyclization 
could not be determined, nor could the benzofuran ring be reinstalled. 
Efforts are ongoing to determine an appropriate substituent to install at the α-
position of the dienone to affect the cyclization in good yield, without causing the 
opening of the benzofuran ring system.  The introduction of a bromide at the α-position 
should provide the extra stabilization of the allylic cation required to promote the 
cyclization effectively.  Cyclization of an α-bromo dienone would also lead to the 
internal double bond after proton loss, which should prevent the furan from opening, as 
well as give a handle to introduce the amide functionality via palladium-catalyzed 
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3.  Experimental Conditions and Compound Data 
 
3.1 General Information 
 Melting points were measured on a Thomas-Hoover capillary tube apparatus and 
are uncorrected.  Infrared spectra were recorded with a Nicolet FT-IR spectrophotometer 
as thin films on a NaCl disc.  1H NMR spectra were recorded on a General Electric QE-
300 spectrometer at 300 MHz as solutions in the indicated solvents and are reported in 
parts per million (ppm) relative to tetramethylsilane and referenced internally to 
protonated residual solvent.  13C spectra were recorded at 75 MHz on a General Electric 
QE-300 spectrometer, and are referenced internally to the indicated solvent.  Mass 
spectra were obtained on either a VG ZAB2E or a Finnegan TSQ70 spectrometer using 
CI. 
 All reactions requiring anhydrous conditions were performed in oven-dried (110o 
C for >30 min.) or flame-dried glassware under an atmosphere of argon.  Anhydrous 
solvents were distilled under dry nitrogen as follows:  CH2Cl2 and 1,2-DCE from CaH2; 
THF and Et2O from sodium benzophenone ketyl. Reagents were purified according to 
methods in Armarego and Chai.1 Alkyllithium reagents were titrated against N-
benzylamide in accordance with the literature procedure.2  Reactions were monitored 
using thin-layer chromatography on glass-backed plates coated with silica gel containing 
a fluorescent indicator (25 µm Silica Gel 60, F254) and were visualized using standard 
techniques: UV fluorescence (254 or 365 nm); phosphomolybdic acid stain.  Flash 
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column chromatography was preformed on silica gel (Kieselgel 60, 40-60 µm), with the 



























 To a mixture of 2-iodo-1,3,5-trimethoxybenzene (8.75 g, 29.8 mmol) and 4-
methoxyphenylacetylene (7.88 g, 59.6 mmol) in dry DMF (60 mL) was added 
triethylamine (60 mL) followed by CuI (0.167 g, 0.877 mmol) and Pd(PPh3)2Cl2 (0.635 g, 
0.905 mmol).  The solution was heated to 80 oC for 16 hours, then concentrated via rotary 
evaporation.  The dark brown oil was partitioned between CH2Cl2 (250 mL) and water 
(250 mL).  The separated organic layer was washed with water (200 mL), dried (MgSO4), 
filtered and concentrated.  Purification by flash column chromatography (SiO2, 20% 
EtOAc in hexane) gave the title compound as a yellow-orange solid (8.69 g, 98%).  Mp. 
120-121 oC. Rf  = 0.25 (25% EtOAc in hexane). IR (thin film) 2939, 2838, 1608, 1576 
cm-1. 1H NMR (300 MHz, CDCl3) δ 7.49 (2H, d, J = 8.7 Hz), 6.85 (2H, d, J = 8.7 Hz), 
6.13 (2H, s), 3.89 (6H, s), 3.83 (3H, s), 3.82 (3H, s).  13C NMR (75 MHz, CDCl3) δ 
161.8, 161.2, 158.9, 132.7, 116.2, 113.5, 95.9, 94.4, 90.3, 80.3, 55.8, 55.1, 55.0.  HRMS 












 To a stirred solution of acetylene 1.5.21 (2.34 g, 7.84  mmol) in acetonitrile (20 
mL), water (30 mL) and carbon tetrachloride (20 mL) was added NaIO4 (6.88 g, 32.2 
mmol) followed by RuCl3 (35.8 mg, 0.172mmol).   The solution was stirred vigorously 
for 1 hour, then diluted with water (70 mL) and extracted with CH2Cl2 (2 x 150 mL).  The 
combined organic extracts were dried (Na2SO4), filtered through Celite and concentrated.  
Purification by flash column chromatography (SiO2, 50% EtOAc in hexane) yielded the 
title compound as a pale yellow solid (1.31 g, 51%).  Mp. 134-136 oC.  Rf = 0.21 (50% 
EtOAc in hexane). IR (thin film) 1666, 1601, 1576 cm-1. 1H NMR (300 MHz, CDCl3) δ 
7.89 (2H, d, J = 8.6 Hz), 6.91 (2H, d, J = 8.6 Hz), 6.06 (2H, s), 3.83 (3H, s), 3.80 (3H, s), 
3.64 (6H, s).  13C NMR (75 MHz, CDCl3) δ 192.2, 190.9, 165.8, 163.4, 162.9, 131.7, 
125.9, 113.5, 107.6, 90.8, 55.6, 55.4, 55.3.  HRMS calculated for C18H19O6 (MH+) 















 BCl3 (1.0 M solution in CH2Cl2, 11.8 mL, 11.8 mmol) was added to a stirred 
solution of diketone 1.5.3 in anhydrous CH2Cl2 (25 mL) at room temperature.  The 
solution was stirred at room temperature for 1 hour and quenched with the addition of 2N 
HCl (12 mL).  The biphasic mixture was stirred for 30 minutes.  The organic layer was 
then separated, dried (Na2SO4), filtered and concentrated via rotary evaporation.  
Purification by column chromatography (SiO2, 35% EtOAc in hexane) yielded the title 
compound as a pale yellow solid (1.01 g, 82 %). Mp. 124-126 oC.  Rf = 0.32 (50% EtOAc 
in hexane). IR (thin film) 3420, 2940,1674, 1629, 1597 cm-1. 1H NMR (300 MHz, CDCl3) 
δ 7.82 (2H, d, J = 8.8 Hz), 6.93 (2H, d, J = 8.8 Hz), 6.10 (1H, d, J = 1.8 Hz), 5.83 (1H, d, 
J = 1.8 Hz), 3.84 (3H, s), 3.81 (3H, s), 3.45 (3H, s).  13C NMR (75 MHz, CDCl3) δ 197.1, 
168.5, 167.4, 163.9, 162.4, 131.2, 131.1, 125.8, 113.9, 103.5, 93.7, 91.0, 55.7, 55.4, 55.3.  















 Concentrated sulfuric acid (5 drops) was added to a stirred solution of 
hydroxyketone 1.5.31 (1.05 g, 3.38 mmol) and trimethylorthoformate (10.5 mL, 96.0 
mmol) in methanol (30 mL).  The solution was heated at reflux for 16 hours, then cooled 
to room temperature and diluted with Et2O (100 mL).  The solution was washed with 5% 
aqueous NaOH (50 mL) and brine (50 mL).  The organic layer was separated, dried 
(Na2SO4), filtered and concentrated.  Purification by flash column chromatography (SiO2, 
30% EtOAc in hexane) yielded the title compound as a yellow foam (1.10 g, 100%).  Rf = 
0.35 (50% EtOAc in hexane). IR (thin film) 2940, 2838, 1708, 1619, 1592 cm-1. 1H NMR 
(300 MHz, CDCl3) δ 7.50 (2H, dd, J = 2.0, 6.8 Hz), 6.82 (2H, dd, J = 2.0, 6.8 Hz), 6.23 
(1H, d, J = 1.9 Hz), 5.98 (1H, d, J = 1.7 Hz), 3.84 (3H, s), 3.82 (3H, s), 3.72 (3H, s), 3.38 
(3H, s).  13C NMR (75 MHz, CDCl3) δ 191.5, 173.3, 170.5, 160.2, 159.5, 127.4, 126.9, 
113.6, 107.8, 102.9, 93.0, 88.7, 55.9, 55.8, 55.0, 52.2.  HRMS calculated for C18H19O6 

















 n-Butyllithium (2.49 M solution in hexane, 1.35 mL, 3.36 mmol) was added to a 
solution of (2-methylprop-1-enyl)benzene (0.211 g, 1.60 mmol) and TMEDA (0.48 mL, 
3.20 mmol) in anhydrous diethyl ether (5.0 mL) at –78°C.  The solution was warmed to 
22°C and stirred for 22 hours.  To this red-colored solution was added ketone 1.5.4 
(0.105 g, 0.318 mmol) in  Et2O (0.50 mL) and stirring was continued for a further 14 hrs.  
The reaction was quenched with the addition of water (15 mL) and extracted with EtOAc 
(2 x 10 mL).  The combined organic extracts were dried (Na2SO4), filtered, and 
concentrated by rotary evaporation.  The crude product was purified by flash column 
chromatography (SiO2, 10–25% EtOAc in hexane) to give the title compound as a 
colorless oil (32 mg, 22%).  Rf  = 0.22 (25% EtOAc in hexane). IR (thin film) 3504, 
2939, 2837, 1626, 1611, 1598 cm-1. 1H NMR (300 MHz, C6D6) δ 7.59 (2H, dd, J = 2.0, 
6.7 Hz), 7.38 (2H, d, J = 7.4 Hz), 7.20–7.12 (2H, m), 7.02 (1H, t, J = 7.3 Hz), 6.82 (2H, 
dd, J = 2.0, 6.8 Hz), 6.50 (1H, s), 6.24 (1H, d, J = 2.1 Hz), 6.02 (1H, d, J = 2.1 Hz), 3.80 
(1H, d, J = 14.4 Hz), 3.72 (1H, d, J = 14.6 Hz), 3.32 (3H, s), 3.29 (3H, s), 3.17 (3H, s), 
3.11 (3H, s), 2.07 (3H, s).  13C NMR (75 MHz, DMSO-d6) δ 162.0, 159.2,159.0, 157.5, 
138.9, 138.3, 129.9, 128.5, 127.9, 126.7, 126.7, 125.4, 115.9, 113.0, 112.4, 92.2, 89.4, 
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 To crude alcohol 2.1.5 (estimated 1.24 mmol) in CHCl3 (2 mL) was added a few 
drops BCl3.  The dark green solution was stirred at room temperature for 45 minutes.  
Water (5 mL) was added and the layers separated.  The aqueous layer was extracted with 
CH2Cl2 (5 mL).  The combined organic layers were dried (Na2SO4), filtered and 
concentrated.  Purification by column chromatography (SiO2, 20% EtOAc in hexane) 
yielded the title compound as colorless solid (58.9 mg, 11% over 2 steps).  Rf  = 0.18 
(30% EtOAc in hexane). IR (thin film) 2965, 2840, 1703, 1619, 1594, 1510 cm-1. 1H 
NMR (300 MHz, C6D6) δ 7.36 (2H, d, J = 8.8 Hz), 7.30–7.26 (2H, m), 7.15-7.12 (3H, 
m), 6.6 (2H, d, J = 8.8 Hz), 6.37 (1H, s), 6.01 (1H, s), 5.05 (1H, s), 4.78 (1H, s), 4.38 
(1H, s), 3.91 (3H, s), 3.85 (3H, s), 3.67 (3H, s), 1.63 (3H, s).  13C NMR (75 MHz, CDCl3) 
δ 195.9, 169.5, 159.2, 158.6, 143.2, 138.1, 129.9, 129.7, 129.3, 127.6, 127.5, 126.1, 
125.9, 114.9, 113.3, 113.2, 95.1, 92.9, 88.6, 58.4, 55.8, 55.6, 54.9, 22.9.  HRMS 















 p-Toluenesulfonyl chloride (31.0 mg, 0.165 mmol) was added to a stirred solution 
of alcohol 2.1.1 (32.4 mg, 0.070 mmol) in a mixture of pyridine (0.2 mL) and 1,2-
dichloroethane (1 mL).  The solution was heated at 50 oC for a period of 4 hours, at 
which time the yellow solution was allowed to cool to room temperature.  The reaction 
mixture was partitioned between EtOAc (10 mL) and saturated aqueous NaHCO3 (10 
mL).  The organic extract was dried (Na2SO4), filtered and concentrated by rotary 
evaporation to yield the title compound as a pale yellow oil (14.0 mg, 45%) as an 
approximately 65:35 mixture of geometric isomers.  Rf 0.50 (35% EtOAc in hexane). IR 
(thin film) 3000, 2936, 2836, 1618, 1590 cm-1. 1H NMR (300 MHz, CDCl3) δ 
7.94(0.65H, s), 7.53– 7.42 (2.35H, m), 7.39–7.08 (5H, m), 6.86–6.78 (2H, m), 6.58 
(0.35H, br s), 6.28 (0.65H, br s), 6.10 (0.35H, d, J = 2.1 Hz), 6.08 (0.35H, d, J = 2.0 Hz), 
6.03 (1.3H, s), 3.95 (1.05H, s), 3.79 (1.05H, s), 3.78 (1.05H, s), 3.77 (1.95H, s), 3.76 
(1.95H, s), 3.73 (1.95H, s), 3.44 (1.05H, s), 3.38 (1.95H, s), 1.71 (1.95H, d, J = 1.0), 1.61 
(1.05H, s).  13C NMR (75 MHz, CDCl3, several signals are not distinguishable) δ 162.4, 
161.0, 160.8, 159.5, 159.3, 156.5, 138.0, 137.9, 134.6, 133.6, 133.4, 133.0, 131.6, 131.1, 
129.9, 129.3, 128.9, 127.7, 127.6, 127.2, 126.9, 126.0, 124.2, 113.1, 112.9, 91.6, 91.5, 
87.4, 55.3, 55.2, 55.1, 55.0, 54.9, 50.6, 50.6, 23.5, 17.3. HRMS calculated for C28H29O5 
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 To ethyl vinyl ether (3.41 mL, 35.4 mmol) and TMEDA (5.31 mL, 35.4 mmol) in 
dry Et2O (40 mL) at 0 oC under argon was added n-BuLi (2.48 M, 14.3 mL, 35.43 mmol).  
The reaction mixture was warmed to room temperature over 45 minutes, then cooled 
again to 0 oC.  (E)-2-(4-methoxyphenyl)-3-phenylacrylic acid4 (3.00 g, 11.8 mmol) in dry 
THF (40 mL) was added and the mixture was stirred for 20 minutes at 0 oC.  The mixture 
was then poured onto brine (50 mL) and extracted with Et2O (2 X 50 mL).  The organic 
extracts were dried (Na2SO4), filtered and concentrated via rotary evaporation.  The 
product was obtained as an orange oil (3.50 g, 96 %). Rf = 0.50 (30% EtOAc in hexane). 
IR (thin film) 2933, 2837, 1663, 1606, 1512 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.31 
(1H, s), 7.20-7.16 (4H, m), 7.12 (2H, d, J = 8.1 Hz), 6.85 (2H, d, J = 8.1 Hz), 5.01 (1H, d,  
J = 2.2 Hz), 4.59 (1H, d,  J = 2.9 Hz), 3.82 (3H, s), 3.73 (2H, q, J = 7.36 Hz), 1.26 (3H, t, 
J = 7.36 Hz).  13C NMR (75 MHz, DMSO-D6) δ 193.2, 159.3, 158.1, 139.7, 139.0, 134.9, 
130.9, 130.5, 129.7, 129.6, 128.9, 128.4, 114.6, 57.2, 55.5, 14.4.  HRMS calculated for 










 To dienone 2.2.9 (733 mg, 2.38 mmol) in MeOH (10 mL) at room temperature was 
added concentrated H2SO4 (0.2 mL).  The mixture was stirred at room temperature for 1.5 
hours, then poured onto water (20 mL).  The reaction mixture was extracted with EtOAc 
(2 X 25 mL) and organic layer was washed with brine (10 mL), dried (Na2SO4), filtered 
and concentrated via rotary evaporation. Purification by flash column chromatography 
(SiO2, 20-25% EtOAc in hexane) yielded the title compound as an off-white solid (633 
mg, 95%). Mp. 167-169 oC.  Rf = 0.32 (30% EtOAc in hexane). IR (thin film) 3275, 
2959, 2837, 1683, 1603, 1514 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.64 (2H, d, J = 9.6 
Hz), 7.18-7.05 (5H, m), 6.73 (2H, d, J = 9.6 Hz), 4.34 (1H, dd, J = 1.5, 6.6 Hz), 3.67 (3H, 
s), 2.97 (1H, dd, J = 6.6, 19 Hz), 2.25 (1H, dd, J = 1.5, 19 Hz).  13C NMR (75 MHz, 
CDCl3) δ 202.3, 160.1, 148.5, 131.0, 130.7, 129.0, 128.2, 126.9, 126.8, 114.1, 113.8, 











 To ketone 2.2.8 (145 mg, 0.56 mmol) in dry THF (3 mL) at -78 oC was added LAH 
(2M in THF, 0.65 mL, 1.29 mmol).  The reaction mixture was stirred at -78 oC for 15 
min, then EtOAc (10 mL) was added and the mixture was warmed to room temperature 
over 30 minutes.  Saturated aq. Na2SO4 (10 mL) was added and the mixture was stirred 
vigorously for 30 minutes.  Solid Na2SO4 was added until it remained granular.  The solid 
was filtered and washed with EtOAc.  The organic layer was concentrated by rotary 
evaporation. Purification by flash column chromatography (SiO2, 30% EtOAc in hexane) 
yielded the title compound as an orange foam (134 mg, 85%). Rf = 0.16 (30% EtOAc in 
hexane). IR (thin film) 3423, 2956, 2930, 2836, 1749, 1514 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.19-7.13 (3H, m), 7.07-7.05 (2H, m), 6.85 (2H, dd, J = 2.2, 8.8 Hz), 6.70 (2H, 
dd, J = 2.2, 8.8 Hz), 4.30 (1H, dd, J = 8.1, 11.7 Hz), 3.65 (3H, s), 3.34-3.25 (1H, m), 
2.76-2.67 (1H, m), 1.95 (1H, q, J = 11.7 Hz), 1.21-1.13 (1H, m). HRMS calculated for 











 To enol 2.2.8 (254 mg, 0.91 mmol) in dry CH2Cl2 (4 mL) at -78 oC under argon was 
added triethylamine (0.25 mL, 1.80 mmol) and triflic anhydride (0.20 mL, 1.18 mmol).  
The reaction mixture was warmed to room temperature over 30 minutes, then water (10 
mL) was added.  The solution was diluted with CH2Cl2 (15 mL) and the phases were 
separated.  The organic layer was concentrated by rotary evaporation. Purification by 
flash column chromatography (SiO2, 20% EtOAc in hexane) yielded the title compound 
as a tan solid (332 mg, 89%). Mp. 121-123 oC.  Rf = 0.43 (30% EtOAc in hexane). IR 
(thin film) 2934, 2840, 1723, 1603, 1513, 1423 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.57 
(2H, dd, J = 2.2, 6.6 Hz), 7.31-7.22 (3H, m), 7.21-7.14 (2H, m), 6.85 (2H, dd, J = 2.2, 6.6 
Hz), 4.57 (1H, dd, J = 2.2, 7.36 Hz), 3.80 (3H, s), 3.13 (1H, dd, J = 7.36, 19.1 Hz), 2.47 
(1H, dd, J = 1.5, 19.1 Hz).  13C NMR (75 MHz, CDCl3) δ 196.2, 162.2, 159.7, 142.3, 
141.3, 131.0, 129.4, 127.5, 126.9, 122.2, 114.4, 113.9, 55.3, 43.2, 42.5.  HRMS 










 To 4-methoxyphenylacetic acid (3.50 g, 21.0 mmol) in dry benzene (6 mL) at 0 oC 
under argon was added oxalyl chloride (3 mL).  The reaction mixture was allowed to 
warm to room temperature over 16 hours.  The solvent was removed by rotary 
evaporation and the residue was dissolved in dry CH2Cl2 (25 mL).  1,3,5-
trimethoxybenzene (3.46 g, 20.6 mmol) was added and the solution was cooled to 0 oC.  
AlCl3 (3.08 g, 23.1 mmol) was slowly added to the reaction mixture over 10 minutes and 
the reaction was stirred at 0 oC for one hour, then allowed to warm to room temperature 
over 14 hours.  The reaction mixture was poured onto ice/water (50 mL) and diluted with 
CH2Cl2 (50 mL).  The phases were separated and the organic layer was washed with 
saturated NaHCO3 (10 mL), then dried (Na2SO4), filtered and concentrated to give the 
title compound as a yellow oil which was used without further purification (6.5 g, 100 
%).  Rf = 0.22 (30% EtOAc in hexane). IR (thin film) 2936, 2835, 1697, 1606, 1513 cm-1.  
1H NMR (300 MHz, CDCl3) δ 7.01 (2H, d, J = 8.1 Hz), 6.70 (2H, d, J = 8.8 Hz), 5.95 
(2H, s), 3.86 (2H, s), 3.69 (3H, s), 3.66 (3H, s), 3.62 (6H, s).  13C NMR (75 MHz, CDCl3) 
δ 201.8, 162.2, 158.1, 157.9, 130.6, 126.8, 113.4, 90.4, 90.3, 55.6, 55.2, 55.0, 50.4.  











 To ketone 2.2.20 (614 mg, 1.94 mmol) and benzaldehyde (0.20 mL, 1.94 mmol) in 
dry benzene (5 mL) was added piperidine (0.25 mL) and glacial acetic acid (0.5 mL).  
The solution was heated at reflux with a dean-stark trap for 26 hours.  The reaction 
mixture was cooled to room temperature and poured onto water (15 mL).  The aqueous 
layer was extracted with EtOAc (2 x 20 mL) and the combined organic layers were dried 
(Na2SO4), filtered and concentrated by rotary evaporation. Purification by flash column 
chromatography (SiO2, 30% EtOAc in hexane) yielded the title compound as a yellow 
solid (599 mg, 76%). Mp. 117-118 oC.  Rf = 0.23 (30% EtOAc in hexane). IR (thin film) 
2996, 2932, 2839, 1653, 1604, 1511 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.35 (2H, d, J = 
8.1 Hz), 7.17-7.12 (4H, m), 7.05-7.03 (2H, m), 6.86 (2H, d, J = 8.1 Hz), 6.10 (2H, s), 
3.79 (3H, s), 3.78 (3H, s), 3.73 (6H, s).  13C NMR (75 MHz, CDCl3) δ 196.6, 162.1, 
159.0, 158.4, 142.4, 140.8, 140.7, 135.4, 131.0, 130.6, 128.7, 128.4, 128.1, 113.8, 90.6, 














 To ethyl vinyl ether (0.03 mL, 0.32 mmol) in dry THF (0.6 mL) at -78 oC under 
argon was added t-BuLi (1.48 M in pentane, 0.44 mL, 0.64 mmol) dropwise.  The 
mixture was allowed to warm to room temperature over 45 minutes, then cooled to -78 oC 
again.  Enone 2.2.21 (65.1 mg, 0.16 mmol) in dry THF (0.6 mL) was added and the 
reaction mixture was stirred at -78 oC for 5 minutes.  Water (3 mL) was added and the 
reaction mixture was warmed to room temperature over 20 minutes.  The mixture was 
extracted with EtOAc (10 mL) and the organic extract was dried (Na2SO4), filtered and 
concentrated by rotary evaporation. Purification by flash column chromatography (SiO2, 
20% EtOAc in hexane) yielded the title compound as a mixture of diastereomers as a 
colorless oil (66 mg, 87%). Rf = 0.43 (30% EtOAc in hexane). IR (thin film) 2937, 2837, 
1603, 1515 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.38-7.18 (5H, m), 6.87 (1H, d, J = 8.8 
Hz), 6.80 (1H, d, J = 8.8 Hz), 6.53 (2H, d, J = 8.8 Hz), 6.20 (2H, s), 4.38 (0.5H, s), 4.28 
(0.5H, s), 3.87 (1.5H, s), 3.83 (1.5H, s), 3.77 (6H, s), 3.64 (3H, s), 3.52 (2H, q, J = 6.6 
Hz),  1.76 (1.5H, s), 1.58 (1.5H, s), 0.82 (3H, q, J = 6.6Hz).  13C NMR (75 MHz, CDCl3) 
δ 162.5, 162.3, 156.8, 156.7, 143.8, 143.5, 140.3, 138.3, 130.1, 129.1, 128.5, 127.9, 
127.4, 127.2, 126.9, 126.2, 115.4, 115.1, 113.6, 113.3, 113.1, 109.0, 108.8, 103.6, 91.2, 
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91.0, 61.0, 60.7, 58.2, 57.2, 55.9, 55.4, 54.9, 30.9, 25.2, 21.7, 15.9, 15.3. HRMS 




























 To dihydrofuran 2.2.22 in a 1:1 mixture of dioxane and water was added a few 
drops of concentrated H2SO4.  After 5 minutes a tan solid crashed out of the solution.  
The solid was collected by filtration and washed with water to yield the product as a tan 
solid.  The yield was not determined. Mp. 149-150 oC.  Rf = 0.43 (30% EtOAc in 
hexane). IR (thin film) 2960, 2936, 2837, 1608, 1584, 1516 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.22-7.16 (5H, m), 6.86 (2H, d, J = 8.1 Hz), 6.62 (2H, d, J = 8.8 Hz), 6.08 (2H, 
s), 3.81 (3H, s), 3.70 (3H, s), 3.56 (6H, s), 2.41 (3H, s).  13C NMR (75 MHz, CDCl3) δ 
162.0, 160.2, 157.7, 148.1, 133.9, 130.0, 127.9, 127.8, 126.9, 126.0, 124.3, 121.5, 120.6, 
112.9, 90.9, 90.7, 55.8, 55.3, 55.0, 12.8.  HRMS calculated for C27H27O5 (MH+) 














 To 4-methoxyphenylacetylene (4.0 g, 30.3 mmol) in anhydrous THF (100 mL) at -
78oC under an atmosphere of argon, was added n-BuLi (2.4 M, 15.8 mL, 37.9 mmol).  
The solution was warmed to room temperature over 30 min.  The solution was then re-
cooled to -78oC and methyl chloroformate (2.58 mL, 33.3 mmol) was added.  The 
solution was warmed to room temperature over 1 hour.  The reaction was quenched with 
saturated aqueous NH4Cl (50 mL).  The aqueous layer was extracted with EtOAc (2 x 50 
mL) and the combined organic extracts were washed with water (20 mL), dried (Na2SO4), 
filtered and concentrated via rotary evaporation.  Purification via flash column 
chromatography (SiO2 5-20% EtOAc in hexane) afforded ester 2.3.4 as a light yellow 
solid (4.51 g, 78%).  Rf =  0.49 (30% EtOAc in hexanes) Mp. 42-43 oC  IR (thin film) 
2951, 2839, 1706, 1603, 1509 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.56 (2H, dd, J = 2.0, 
6.7 Hz), 6.89 (2H, dd, J = 2.0, 6.7 Hz), 3.843 (3H, s), 3.836 (3H, s).  13C NMR(75 MHz, 
CDCl3) δ 161.5, 154.7, 135.0, 114.3, 111.2, 87.4, 79.8, 55.4, 52.7.  HRMS calculated for 













 3,5-dimethoxyphenol (926 mg, 6.02 mmol), acetylene 2.3.4 (1.16 g, 6.015 mmol), 
and DABCO (135 mg, 1.20 mmol) were dissolved in wet DMF (50 mL).  The solution 
was heated at 100o C for 14 hours. The solution was cooled to room temperature and 
water (50 mL) was added. The aqueous layer was extracted with diethyl ether (2 x 100 
mL) and the ethereal solution was washed with water (4 x 50 mL) and saturated aqueous 
NaCl (50 mL).  The organic layer was dried (Na2SO4), filtered and concentrated under 
reduced pressure to yield the crude product as a yellow paste (2.01 g, 97%). Rf = 0.40 
(30% EtOAC in hexane) The crude product was taken on as a 5:1 E/Z mixture of 
diastereomers. IR (thin film) 3007, 2948, 1723, 1606, 1512 cm-1. E-isomer- 1H NMR 
(300 MHz, CDCl3) δ 7.53 (2H, dd, J = 1.6, 8.9 Hz), 6.85 (2H, dd, J = 1.9, 8.8 Hz), 6.15 
(2H, d, J = 2 Hz), 6.09 (1H, d, J = 2 Hz), 6.07 (1H, s), 3.81 (3H, s), 3.72 (6H, s), 3.69 
(3H, s). 13C NMR(75MHz, CDCl3) δ 165.0, 161.7, 161.6, 161.4, 158.7, 131.1, 128.6, 
114.2, 95.1, 94.5, 94.1, 55.5, 55.34, 55.31, 51.3.  Z-isomer 1H NMR (300 MHz, CDCl3) δ 
7.62 (2H, dd, J = 2.0, 8.8 Hz), 6.94 (2H, dd, J = 1.9, 8.8 Hz), 6.31 (1H, d, J = 2.2 Hz), 
6.28 (2H, d, J = 2.2 Hz), 5.25 (1H, s), 3.86 (3H, s), 3.78 (6H, s), 3.60 (3H, s). 13C 
(75MHz, CDCl3) δ 179.0, 161.6, 161.2, 158.8, 155.8, 131.1, 128.6, 114.2, 99.6, 97.4, 













 To dimethyl methylphosphonate (0.42 mL, 3.85 mmol) in anhydrous THF (10 mL) 
at -78 oC under an atmosphere of argon, was added n-BuLi (2.49 M, 1.62 mL, 4.038 
mmol).  This solution was stirred at -78 oC for 15 minutes, when ester 2.3.3 (444 mg, 
1.28 mmol) in anhydrous THF (8 mL + 2 mL rinse) was added dropwise.  The reaction 
was stirred at -78 oC for 15 minutes and then quenched with 0.5 N HCl (30 mL).  The 
aqueous layer was extracted with EtOAc (2 x 50 mL), and the combined organic extracts 
were dried (Na2SO4), filtered and concentrated.  Compound 2.3.6 was purified by flash 
column chromatography (SiO2 eluting with 100% EtOAc) and isolated as a yellow oil 
(559 mg, 80%).  Rf = 0.28 (100% EtOAc).  Mixture of diastereomers.  IR (thin film) 
3006, 2955, 2835, 1681, 1600, 1510, 1475 cm-1.  1H NMR major component (300 MHz, 
CDCl3) δ 7.51 (2H, dd, J = 1.8, 7.5 Hz), 6.84 (2H, dd, J = 2.0, 7.8 Hz), 6.30 (1H, s), 6.14 
(2H, d, J = 2.0 Hz), 6.11 (1H, d, J = 2.0 Hz), 3.81 (3H, s), 3.78 (3H, s), 3.74 (3H, s), 3.72 
(6H, s), 3.47 (1H, s), 3.40 (1H, s). 13C NMR (75MHz, CDCl3) δ 189.5 (d, JC,P = 7.3 Hz), 
169.8, 161.7, 161.4, 161.37, 129.1, 125.5, 114.2, 99.5, 95.9, 95.0, 55.26, 55.23, 52.8 (d, 
JC,P = 7.1 Hz), 40.8 (d, JC,P = 121.2 Hz). HRMS calculated for C21H26O8P (MH+) 











 To phosphonate 2.3.6 (134 mg, 0.28 mmol) in THF (5 mL) at 0 oC under an 
atmosphere of argon, was added NaH (60% dispersion in mineral oil, 22 mg, 0.56 mmol).  
The solution was allowed to warm to room temperature over 15 minutes, then freshly 
distilled benzaldehyde (0.14 mL, 1.4 mmol) was added.  The reaction was stirred at room 
temperature for 20 minutes and then quenched with saturated aqueous NH4Cl (10 mL).  
The organic layer was diluted with EtOAc (10 mL) and separated.  The organic layer was 
washed with water (10 mL), dried (Na2SO4), filtered and concentrated.  Purification by 
flash column chromatography (SiO2 10-25% EtOAc in hexane) yielded the title 
compound as a bright yellow solid (116 mg, 97%).  Rf = 0.46 (30% EtOAc in hexanes).  
Mixture of diastereomers.  Mp. 103-106 oC.  IR (thin film) 2959, 2940, 2839, 1638, 1603, 
1510 cm-1.  1H NMR major component (300 MHz, CDCl3) δ 7.61 (1H, d, J = 16 Hz), 7.59 
(2H, dd, J = 2.0, 8.9 Hz), 7.48-7.31 (5H, m), 7.33 (1H, d, J = 14 Hz), 6.88 (2H, dd, J = 
1.8, 8.0 Hz), 6.44 (1H, s), 6.18 (2H, d, J = 2.1 Hz), 6.11 (1H, d, J = 2.1 Hz), 3.83 (3H, s), 
3.70 (6H, s).  13C NMR major component (75 MHz, CDCl3) δ 188.5, 169.5, 161.6, 161.5, 
160.0, 158.4, 135.1, 130.0, 128.8, 128.7, 128.2, 126.9, 126.3, 114.7, 114.3, 95.4, 94.8, 








 To dienone 2.3.2 (60.0 mg, 0.145 mmol) in dry CH2Cl2 (5 mL) at -78 oC under an 
atmosphere of argon, was added TiCl4 (0.02 mL, 0.145 mmol).  The solution was allowed 
to warm to room temperature over 1 hour and quenched with the addition of water (7 
mL).  The aqueous layer was extracted with CH2Cl2 (10 mL) and the combined organic 
fractions were dried (Na2SO4), filtered and concentrated. Purification by column 
chromatography (SiO2, 40% EtOAc in hexane) yielded the title compound as a dark 
crimson paste (33.1 mg, 55%).  Rf = 0.12 (30% EtOAc in hexane). IR (thin film) 3310, 
2952, 2936, 2839, 1602, 1511 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.60 (1H, d, J = 15.8 
Hz), 7.44-7.34 (7H, m), 7.02 (1H, s), 6.87 (2H, d, J = 8.7 Hz), 6.78 (1H, d, J = 16.1 Hz), 
6.27 (1H, d, J = 2.1 Hz), 6.11 (1H, d, J = 2.1 Hz), 6.05 (1H, s), 3.83 (3H, s), 3.80 (3H, s), 
















 To dry CH3CN (0.08 mL, 1.45 mmol) in dry THF (1.5 mL) under argon at -78 oC 
was added n-BuLi (2.46 M in hexane, 0.60 mL, 1.45 mmol).  Stirred at -78 oC for 1 hour, 
then ester 2.3.3 (100 mg, 0.29 mmol) in dry THF (1.5 mL) was added dropwise via 
syringe.  The solution was stirred for 10 minutes at -78 oC, then quenched with sat. 
aqueous NH4Cl (10 mL) and allowed to warm to room temperature.  The mixture was 
extracted with EtOAC (2 x 10mL) and the combined organic extracts were dried 
(Na2SO4), filtered and concentrated by rotary evaporation. Purification by flash column 
chromatography (SiO2, 20-30% EtOAc in hexane) yielded the title compound as an 
yellow oil (37.1 mg, 36%). Rf = 0.20 (30% EtOAc in hexane). IR (thin film) 3006, 2959, 
2932, 2839, 2217, 1661, 1602, 1511 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.49 (2H, d, J = 
8.7 Hz), 6.86 (2H, d, J = 8.8 Hz), 6.25 (1H, s), 6.10 (2H, s), 3.86 (2H, s), 3.82 (3H, s), 
3.73 (6H, s). 13C NMR (75 MHz, CDCl3) δ 185.8, 163.5, 162.3, 161.8, 157.1, 129.3, 
124.6, 114.5, 114.4, 112.8, 95.9, 95.4, 55.4, 55.4, 33.0.  HRMS calculated for C20H20NO5 
















 To keto-nitrile 2.3.15 (17.9 mg, 0.05 mmol) in CH2Cl2 (0.7 mL) was added 
benzaldehyde (0.03 mL, 0.26 mmol) and silica gel (12 mg).  Stirred at room temperature 
for 36 hours.  The silica gel was then filtered and the solvent removed by rotary 
evaporation.  Purification by flash column chromatography (SiO2, 10-30% EtOAc in 
hexane) yielded the title compound as an organish-yellow oil (18.1 mg, 80%). Rf = 0.23 
(30% EtOAc in hexane). IR (thin film) 3002, 2955, 2929, 2841, 2206, 1660, 1597, 1571, 
1510 cm-1.  1H NMR (300 MHz, CDCl3) δ 8.20 (1H, s), 7.98 (2H, d, J = 7.0 Hz), 7.69 
(2H, d, J = 8.8 Hz), 7.55-7.46 (3H, m), 7.08 (1H, s), 6.91 (2H, d, J = 8.8 Hz), 6.17 (2H, 
s), 3.85 (3H, s), 3.72 (6H, s). 13C NMR (75 MHz, CDCl3) δ 179.5, 164.4, 161.4, 158.8, 
153.3, 152.4, 133.0, 131.6, 131.1, 129.5, 129.2, 129.1, 114.4, 113.4, 110.7, 106.8, 95.2, 













 To 2,4,6-trimethoxybenzaldehyde5 (234 mg, 1.19 mmol) in dry CH2Cl2 (3 mL) at 0 
oC under argon was added BCl3 (1M in CH2Cl2, 1.79 mL, 1.79 mmol).  The reaction 
mixture was warmed to room temperature over 45 minutes, then quenched with 1N HCl 
(10 mL) and water (10 mL) was added.  The aqueous layer was extracted with CH2Cl2 (2 
x 5 mL) and the organic fractions dried (Na2SO4), filtered and concentrated to yield the 
title compound as a white solid (216 mg, 100%). Rf = 0.23 (30% EtOAc in hexane).  All 





















 Dry HCl was bubbled through a solution of aldehyde 2.4.9 (993 mg,  5.45 mmol) 
and 4′-methoxypropiophenone (900 mg, 5.45 mmol) in dry EtOAc (5 mL) for 10 
minutes.  The flask was capped and allowed to stand at room temperature for 23 hours 
where a dark crimson solid had precipitated.  The solid was filtered and dried under 
vacuum.  The red salt (470 mg, 1.36 mmol) was dissolved in MeOH (5 mL) and 4N HCl 
(1 mL) and H2O2 (30% aqueous, 2.1 g, 13.6 mmol) was added.  A solid immediately 
crashed out of the solution.  The reaction was allowed to go for 30 minutes, then the solid 
was filtered and washed with water to give the title compound as an off-white foam (66.0 
mg, 15% from salt).  Rf = 0.46 (30% EtOAc in hexane). IR (thin film) 3003, 2964, 2939, 
2839, 1689, 1611, 1505 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.76 (2H, dd, J = 2.0, 8.8 
Hz), 6.96 (2H, dd, J = 2.0, 8.8 Hz), 6.68 (1H, d, J = 2.2 Hz), 6.37 (1H, d, J = 2.2 Hz), 
3.90 (3H, s), 3.87 (3H, s), 3.85 (3H, s), 2.59 (3H, s).  13C NMR (75 MHz, CDCl3) δ 
199.8, 160.7, 159.6, 155.3, 153.3, 152.0, 128.6, 122.8, 116.8, 114.0, 110.6, 94.8, 88.4, 












 To a mixture of sodium tert-butoxide (1.30 g, 13.5 mmol), Pd(OAc)2 (60.0 mg, 
0.266 mmol) and tricyclohexylphosphine (74.5 mg, 0.266 mmol) in dry dioxane (23 mL) 
and under an argon atmosphere was added 2-iodo-1,3,5-trimethoxybenzene (3.91 g, 13.3 
mmol) and 4’-methoxyacetophenone (1.99 g, 13.3 mmol).  The reaction mixture was 
heated to 100 oC for 6.25 hours then cooled to room temperature.  The reaction mixture 
was diluted with Et2O (100 mL) and the organic layer was washed with water (50 mL).  
The aqueous layer was extracted with EtOAc (60 mL) and the combined organic layers 
were washed with brine (30 mL), dried (Na2SO4), filtered and concentrated via rotary 
evaporation.  Recrystallization from 95% EtOH yielded the title compound as an off-
white solid (3.40 g, 81%). Mp. 134-135 oC.  Rf = 0.24 (30% EtOAc in hexane). IR (thin 
film) 2936, 2835, 1684, 1599 cm-1.  1H NMR (300 MHz, CDCl3) δ 8.01 (2H, d, J = 8.8 
Hz), 6.92 (2H, d, J = 8.8 Hz), 6.15 (2H, s), 4.20 (2H, s), 3.86 (3H, s), 3.81 (3H, s), 3.73 
(6H, s).  13C NMR (75 MHz, CDCl3) δ 196.8, 163.0, 160.2, 158.8, 130.3, 113.5, 113.4, 











 To ketone 2.4.13 (104 mg, 0.33 mmol) in dry CH2Cl2 (1.5 mL) at room temperature 
under an argon atmosphere was added BCl3 (0.33 mL, 0.33 mmol).  The reaction mixture 
was stirred at room temperature for 5 minutes then poured onto water (10 mL).  The 
layers were separated and aqueous layer was extracted with CH2Cl2 (20 mL).  The 
combined organic layers were dried (Na2SO4), filtered and concentrated. Purification by 
flash column chromatography (SiO2, 20% EtOAc in hexane) yielded the title compound 
as a white crystalline solid (53.2 mg, 52%).  Mp. 97-98 oC.  Rf = 0.46 (30% EtOAc in 
hexane). IR (thin film) 3000, 2937, 2836, 1616, 1506, 1498 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.72 (2H, dd, J = 1.8, 7.1 Hz), 6.96 (2H, dd, J = 1.9, 6.7 Hz), 6.90 (1H, s), 6.69 
(1H, d,  J = 1.7 Hz), 6.33 (1H, d,  J = 1.7 Hz), 3.92 (3H, s), 3.86 (3H, s), 3.85 (3H, s).  13C 
NMR (75 MHz, CDCl3) δ 159.4, 158.8, 156.4, 153.8, 153.3, 125.7, 123.7, 114.2, 113.4, 














To a suspension of 3,5-dimethoxyphenol (2.57 g, 16.66 mmol) and H2O2 (30% 
solution, 1.23 g, 10.83 mmol) in H2O (30 mL), was added iodine (2.11 g, 8.33 mmol).  
The solution was stirred at room temperature for 1 hour until the solution became clear.  
The aqueous solution was extracted CH2Cl2 (60 mL), and washed with 5% aqueous 
Na2S2O3 (30 mL) and H2O (30 mL).  The organic layer was dried (Na2SO4), filtered, and 
concentrated under reduced pressure.  Purification via flash column chromatography 
(SiO2 eluting with 10% EtOAc/hexanes) gave iodophenol 2.4.15 as a colorless solid (3.03 
g, 65%)  Rf = 0.30 (30% EtOAc in hexanes). Mp. 61-64 oC.  IR (thin film) 3462, 3003, 
2940, 2840, 1587, 1465 cm-1.  1H NMR (300 MHz, CDCl3) δ 6.29 (1H, d, J = 2.9 Hz), 
6.07 (1 H, d, J = 2.8 Hz), 5.51 (1H, s), 3.85 (3H, s), 3.79 (3H, s).  13C NMR (75 MHz, 
CDCl3) δ 161.9, 158.7, 156.2, 92.7, 91.7. 66.8, 56.1, 55.2.  HRMS calculated for 
C8H10O3I (MH+) 280.9675.  Found 280.9678. 4-iodo-3,5-dimethoxyphenol was isolated 
as a tan solid (1.49 g, 32%) Rf = 0.12 (30% EtOAc in hexanes) Mp. 122-123 oC.  IR (thin 
film) 3413, 1602, 1584, 1559 cm-1.  1H NMR (300 MHz, DMSO-d6) δ 9.76 (1H, s), 6.11 
(2H, s), 3.73 (6H, s). 13C NMR (75 MHz, DMSO-d6) δ 160.0, 159.2, 92.7, 64.0. 46.1.  










To a stirred solution of 4-methoxyphenylacetylene (1.58 g, 12.01 mmol) and 
iodophenol 2.4.15 (3.06 g, 10.92 mmol) in anhydrous THF (25 mL) at 0°C under an 
atmosphere of argon, was added ethylmagnesium bromide (2.5 M solution in ethyl ether, 
9.17 mL, 22.93 mmol) drop-wise.  After 5 minutes at this temperature, the solution was 
allowed to warm briefly to room temperature and 
dichlorobis(triphenylphosphine)palladium(II) (146 mg, 0.21 mmol) was added. The 
solution was heated at reflux for 2 hours at which time the cloudy yellow solution was 
quenched with the addition of ice (ca. 15 g).  The reaction mixture was diluted with 0.5 
M aqueous HCl (40 mL) and extracted with EtOAc (2 x 80 mL).  The combined organic 
extracts were subsequently dried (Na2SO4), filtered, and concentrated by rotary 
evaporation.  Purification over SiO2 eluting with 20% EtOAc/hexanes yielded the title 
compound as a pale yellow solid (2.55 g, 82%) Rf = 0.33 (30% EtOAc in hexanes). Mp. 
86–87 °C .  IR (thin film) 3472, 3002, 2963, 2936, 2839, 1620, 1576, 1515, 1457 cm-1. 1H 
NMR (300 MHz, CDCl3) δ 7.49 (2H, dd, J = 1.6, 7.2 Hz), 6.88 (2H, dd, J = 2.0, 6.8 Hz), 
6.20 (1H, d, J = 2.1 Hz), 6.06 (1H, d, J = 2.1), 5.99 (1H, s), 3.87 (3H, s), 3.84 (3H, s), 
3.81 (3H, s).  13C NMR (75 MHz, CDCl3) δ 161.8, 160.9, 159.7, 158.7, 133.1, 115.0, 
113.9, 98.9, 92.4, 92.1, 91.4, 78.2, 56.0, 55.5, 55.3. HRMS calculated for C17H17O4 
(MH+) 285.1127. Found 285.1126. 
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 Carbon monoxide (1 atm, balloon pressure) was bubbled through a solution of 
phenol 2.4.14 (3.01g, 10.58 mmol) in MeOH (60 mL) over a period of 10 min.  Pd(OAc)2 
(48.0 mg, 0.21 mmol), CBr4 (7.72 g, 23.28 mmol), and NaHCO3 (1.96 g, 23.28 mmol) 
were added and the solution stirred vigorously under an atmosphere of carbon monoxide 
for 20 hours.  The solution was diluted with EtOAc (100 mL) and filtered through a silica 
gel plug.  The filtrate was washed with water (20 mL), dried (Na2SO4), filtered, and 
concentrated by rotary evaporation.  The resulting crude oil was chromatographed over 
SiO2 eluting with 10–25% EtOAc/hexanes to yield the title compound 2.4.3 as a yellow 
solid (2.72 g, 75%). Rf = 0.23 (25% EtOAc in hexanes). Mp. 107–108 °C. IR (thin film) 
3001, 2951, 2838, 1730, 1623, 1616, 1506 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.75 (2H, 
dd, J = 9.0, 1.9 Hz,), 6.96 (2H, dd, J = 8.9, 2.1 Hz), 6.66 (1H, d, J = 1.8 Hz), 6.36 (1H, d, 
J = 1.8 Hz), 3.92 (3H, s), 3.89 (3H, s), 3.86 (3H, s). 13C NMR (75 MHz, CDCl3) δ 166.1, 
160.2, 159.4, 155.3, 153.6, 153.4, 128.5, 122.3, 113.9, 110.7, 107.7, 95.1, 87.9, 55.8, 














To dry CH3CN (0.10 mL, 0.28 mmol) in dry THF (0.75 mL) at -78 oC under 
argon was added n-BuLi (2.46 M in hexanes, 0.11 mL, 0.28 mmol).  The mixture was 
stirred at -78 oC for 1 hour.  Ester 2.4.3 (38 mg, 0.11 mmol) in THF (1.0 mL) was added 
to the orange solution and the solution was stirred at -78 oC for 5 minutes.  The reaction 
was quenched with 1N HCl (2 mL) and warmed to room temperature.  The aqueous layer 
was extracted with EtOAc (2 X 5 mL) and the organic layer was dried (Na2SO4), filtered 
and concentrated.  Purification by flash column chromatography (SiO2 20-25% EtOAc in 
hexanes) yielded the title compound 2.4.25 as a yellow solid (19.5 mg, 50 %).  Rf = 0.15 
(30% EtOAc in hexanes)  Mp. 134-136 oC  IR (thin film) 2918, 2839, 2252, 1684, 1609, 
1502 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.87 (2H, d, J = 8.9 Hz), 6.99 (2H, d, J = 8.8 
Hz), 6.72 (1H, d, J = 1.6 Hz), 6.43 (1H, d, J = 1.6 Hz), 4.09 (2H, s), 3.97 (3H, s), 3.88 
(3H, s), 3.87 (3H, s).  13C NMR (75 MHz, CDCl3) δ 187.0, 161.2, 160.0, 155.8, 155.3, 
152.8, 129.9, 121.4, 114.4, 114.2, 114.0, 109.3, 95.5, 88.4, 55.9. 55.8, 55.4, 33.7.  HRMS 
















 To ketone 2.4.25 (17.1 mg, 0.05 mmol) in EtOH (0.5 mL) at room temperature was 
added freshly distilled benzaldehyde (0.01 mL, 0.10 mmol) and piperidine (1 drop).  
Stirred at room temperature for 5 minutes.  1N HCl (2 mL) was added and the aqueous 
layer was extracted with EtOAc (2 x 3 mL).  The combined organic extracts were dried 
(Na2SO4), filtered and concentrated. Purification by flash column chromatography (SiO2, 
10-15% EtOAc in hexane) yielded the title compound as an yellow-orange gum (15.4 
mg, 70%). Rf = 0.40 (30% EtOAc in hexane). IR (thin film) 3007, 2957, 2932, 2834, 
2218, 1668, 1609, 1504 cm-1.  1H NMR (300 MHz, CDCl3) δ 8.02 (1H, s), 7.93 (2H, d, J 
= 7.36 Hz), 7.76 (2H, dd, J = 2.2, 8.8 Hz), 7.54-7.45 (3H, m), 6.95 (2H, dd, J = 2.2, 8.8 
Hz), 6.72 (1H, d, J = 2.2 Hz), 6.35 (1H, d, J = 2.2 Hz), 3.88 (3H, s), 3.84 (3H, s), 3.78 
(3H, s). 13C NMR (75 MHz, CDCl3) δ 182.2, 169.4, 163.8, 162.1, 160.7, 153.0, 152.6, 
133.1,  131.6, 130.5, 128.4, 128.2, 126.8, 125.4, 115.4, 114.4, 108.6, 102.2, 94.5, 93.7, 













 Titanium(IV) chloride (1.0 M in CH2Cl2, 0.28 mL, 0.28 mmol) was added drop-
wise to a stirred solution of benzofuran 2.4.2 (53.5 mg, 0.188 mmol) and freshly prepared  
cinnamoyl chloride (94.0 mg, 0.565 mmol) in anhydrous CH2Cl2 (1.0 mL) at room 
temperature under an atmosphere of argon.  The solution was stirred for 10 min, then 
quenched with the addition of water (3 mL) and extracted with CH2Cl2 (2 x 3 mL).  The 
combined organic extracts were washed sequentially with water (3 mL), saturated 
aqueous NaHCO3 (2 x 3 mL), and saturated aqueous NaCl (1 x 3 mL).  After drying 
(Na2SO4), the solution was filtered and concentrated by rotary evaporation.  Purification 
by flash column chromatography (SiO2, 25–50% EtOAc in hexane) furnished the title 
compound as a yellow solid (38.9 mg, 50%) plus the dienone derived from acylation at 
the 3-position 2.4.21 (26.2 mg, 33%).  Mp. 140–141°C.  Rf  = 0.12 (30% EtOAc in 
hexane). IR (thin film) 3001, 2926, 2849, 1653, 1607 cm-1. 1H NMR (300 MHz, CDCl3) δ 
7.75–7.70 (3H, m), 7.63–7.60 (2H, m), 7.49–7.38 (4H, m), 6.92–6.89 (3H, m), 6.40 (1H, 
s), 4.03 (3H, s), 3.96 (3H, s), 3.83 (3H, s).  13C NMR (75 MHz, CDCl3) δ 188.8, 159.6, 
158.1, 155.4, 154.8, 154.3, 142.3, 135.3, 129.9, 128.7, 128.2, 128.0, 125.9, 123.0, 114.1, 
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 To a stirred solution of dimethylmethylphosphonate (0.17 mL, 1.58 mmol) in 
anhydrous THF (2.0 mL) at –78 °C under an atmosphere of argon was added n-
butyllithium (2.46 M in hexane, 0.64 mL, 1.58 mmol).  After 15 minutes had elapsed, a 
solution of ester 2.4.3 (135 mg, 0.394 mmol) in anhydrous THF (1 mL, rinsing with an 
additional 1 mL of THF) was added via cannula.  The solution was warmed to room 
temperature over a period of 30 min., then heated at reflux for 1.5 hr.  The reaction was 
quenched with the addition of saturated aqueous NH4Cl (20 mL) and extracted with 
EtOAc (2 x 20 mL).  The combined organic extracts were dried (Na2SO4), filtered, and 
concentrated. Purification by flash-column chromatography (SiO2, eluting with 100% 
EtOAc) gave the product 2.4.29 as a pale yellow colored solid (152 mg, 89%).  Mp. 107–
109 °C.  Rf = 0.17 (EtOAc). IR (thin film) 3005, 2955, 2847, 1684, 1623, 1610, 1506 cm-
1.  1H NMR (300 MHz, CDCl3) δ 7.86 (2H, dd, J = 2.1, 6.9 Hz), 6.95 (2H, dd, J = 2.1, 6.9 
Hz), 6.69 (1H, d, J = 1.9 Hz), 6.38 (1H, d, J = 2.0 Hz), 3.91 (3H, s), 3.87 (3H, s), 3.86 
(3H, s), 3.80 (1H, s), 3.73 (1H, s), 3.60 (3H, s), 3.56 (3H, s).  13C NMR (75 MHz, CDCl3) 
δ 191.8 (d, JC,P = 6.15 Hz), 160.6, 159.6, 155.2, 154.0, 153.0, 129.3, 122.1, 116.4, 113.8, 
110.2, 95.1, 88.2, 55.8, 55.7, 55.3, 52.7 (d, JC,P = 6.2 Hz), 42.7 (d, JC,P = 129.5 Hz).  
 173 
HRMS calculated for C21H24O8P (MH+) 435.1209. Found 435.1207.  
 174 
(E)-1-(4,6-dimethoxy-2-(4-methoxyphenyl)benzofuran-3-yl)-3-phenylprop-2-en-1-








 To a stirred solution of phosphonate 2.4.29 (124 mg, 0.286 mmol) in anhydrous 
THF (2 mL) at 0 °C under an atmosphere of argon, was added sodium hydride (60% in 
mineral oil, 20.0 mg, 0.5 mmol).  The solution was allowed to warm to room 
temperature, at which time distilled benzaldehyde (0.15 mL, 1.43 mmol) was added.  The 
solution was heated at reflux for 30 minutes, then cooled to room temperature.  The 
intensely yellow solution was quenched by the addition of saturated aqueous NH4Cl (10 
mL) and extracted with EtOAc (2 x 15 mL).  The combined organic extracts were dried 
(Na2SO4), filtered, and concentrated.  Purification by flash column chromatography 
(SiO2, 10–25% EtOAc in hexane) yielded the dienone 2.4.21 as a viscous yellow wax 
(0.115 g, 99%).  Rf = 0.32 (30% EtOAc in hexane). IR (thin film) 2998, 2955, 2932, 
2934, 1643, 1619, 1610, 1502 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.75 (2H, dd, J = 2.0, 
6.8 Hz), 7.52 (1H, d, J = 16.1 Hz), 7.50–7.46 (2H, m), 7.38–7.34 (3H, m), 7.11 (1 H, d, J 
= 16.1 Hz), 6.91 (2H, dd, J = 2.1, 6.7 Hz), 6.71 (1H, d, J = 2.0 Hz), 6.34 (1H, d, J = 1.5 
Hz), 3.87 (3H, s), 3.81 (3H, s), 3.78 (3H, s).  13C NMR (75 MHz, CDCl3) δ 192.0, 160.1, 
159.6, 155.3, 153.7, 152.4, 144.5, 134.8, 130.4, 128.8, 128.5, 128.4, 127.8, 122.5, 115.2, 
114.1, 111.6, 94.9, 88.0, 55.8, 55.7, 55.3. HRMS calculated for C26H23O5 (MH+)  











 Distilled BF3•OEt2 (0.05 mL, 0.42 mmol) was added drop-wise to a stirred solution 
of dienone 2.4.21 (166 mg, 0.40 mmol) and triethylsilane (0.07 mL, 0.42 mmol) in 
anhydrous CH2Cl2 (3.0 mL) at 0 oC.  The deep purple colored solution was allowed to 
warm to room temperature over a period of 6 hrs.  The reaction was quenched with the 
addition of water (10 mL) and extracted with CH2Cl2 (2 x 15 mL).  The combined organic 
extracts were dried (Na2SO4), filtered, and concentrated by rotary evaporation. The title 
compound was obtained as a pale yellow oil (166 mg, 100 %).  Rf  = 0.57 (30 % EtOAc 
in hexane). IR (thin film) 3001, 2934, 2837, 1700, 1695, 1684, 1623, 1616, 1505 cm-1. 1H 
NMR (300 MHz, CDCl3) δ 7.63 (2H, d, J = 8.9 Hz), 7.27–7.16 (5H, m), 6.89 (2H, d, J = 
9.0 Hz), 6.66 (1H, d J = 1.5 Hz), 6.34 (1H, d, J = 1.8 Hz), 3.86 (3H, s), 3.84 (3H, s), 3.82 
(3H, s), 3.22 (2H, t, J = 7.5 Hz) 3.04 (2H, t, J = 7.5 Hz).  13C NMR (75 MHz, CDCl3) δ 
201.5, 160.2, 159.5, 155.2, 153.3, 151.5, 141.2, 128.5, 128.3, 125.9, 122.4, 116.5, 114.0, 
110.9, 94.8, 88.0, 77.2, 55.8, 55.6, 55.3, 46.0, 30.1.  HRMS calculated for C26H25O5 















To a stirred solution of distilled diethylethylphosphonate (0.29 mL, 1.77 mmol) in 
anhydrous THF (6 mL) at –78 °C under argon, was added n-butyllithium (2.46M solution 
in hexane, 0.72 mL, 1.77 mmol).  After 20 minutes, ester 2.4.3 (202 mg, 0.59 mmol) in 
anhydrous THF (2mL, rinsing with 1 mL) was added drop-wise and the solution stirred 
for one hour at -78 oC.  The reaction was quenched with the addition of saturated aqueous 
NH4Cl (10 mL) and the aqueous layer extracted with EtOAc (2 x 20 mL).  The combined 
organic extracts were washed sequentially with water (15 mL) and saturated aqueous 
NaCl (15 mL), then dried (Na2SO4), filtered, and concentrated.  Chromatography (SiO2, 
EtOAc) yielded the product 2.4.35 as a white crystalline solid (252 mg, 90%). Rf = 0.23 
(EtOAc). Mp. 92–93 °C. IR (thin film) 2979, 2940, 2839, 1684, 1623, 1611, 1505 cm-1. 
1H NMR (300 MHz, CDCl3) δ 7.86 (2H, d, J = 8.8 Hz), 6.93 (2H, d, J = 8.9 Hz), 6.68 
(1H, d, J = 2.1 Hz), 6.36 (1H, d, J = 1.6 Hz), 4.18 (1H, dq, J = 6.9, 25.9 Hz), 3.95–3.62 
(4H, m), 3.89 (3H, s), 3.87 (3H, s), 3.85 (3H, s), 1.56 (3H, dd, J = 6.5, 14.7 Hz), 1.00 
(6H, dt, J = 7.1, 64.3 Hz).  13C NMR (75 MHz, CDCl3) δ 195.6 (d, JC,P = 5.6 Hz), 160.5, 
159.4, 155.1, 153.3, 153.0, 129.1, 122.5, 116.7, 113.7, 110.8, 94.9, 88.1, 62.3–62.0 (m), 
55.8, 55.7, 55.3, 47.4 (d, JC,P = 126.6 Hz), 16.2 (d, JC,P = 5.4 Hz), 15.8 (d, JC,P = 7.2 Hz), 
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To a solution of phosphonate 2.4.35 (839 mg, 1.76 mmol) and anhydrous lithium 
chloride (dried at >200°C/0.3mm Hg for thirty minutes; 104 mg, 2.46 mmol) in 
anhydrous toluene (20 mL) under argon was added freshly distilled DBU (1.05 mL, 7.04 
mmol).  Freshly distilled benzaldehyde (0.89 mL, 8.81 mmol) was added and the pale 
yellow solution heated at reflux under argon for 30 hrs.  The reaction was cooled to room 
temperature and saturated aqueous NH4Cl (30 mL) was added.  The aqueous layer was 
extracted with EtOAc (3 x 20 mL) and the combined organic extracts were washed with 
water (20 mL), dried (Na2SO4), filtered, and concentrated.  The crude product was 
purified by flash column chromatography (SiO2 10–100% EtOAc in hexane) to yield the 
title compound 2.4.36 (557 mg, 74%) as a yellow colored wax.  Rf = 0.37 (30% EtOAc in 
hexanes). IR (thin film) 3002, 2963, 2928, 2854, 1651, 1622, 1505 cm-1. 1H NMR (300 
MHz, CDCl3) δ 7.66 (2H, dd, J = 2.0, 7.0 Hz), 7.39–7.27 (6H, m), 6.91 (2H, dd, J = 2.0, 
6.9 Hz), 6.70 (2H, d, J = 1.7 Hz), 6.30 (1H, d, J = 1.8 Hz), 3.87 (3H, s), 3.82 (3H, s), 3.77 
(3H, s), 2.29 (3H, s).  13C NMR (75 MHz, CDCl3) δ 195.2, 159.7, 159.4, 154.5, 153.0, 
150.0, 141.9, 138.1. 135.2, 129.7, 128.9, 128.5, 127.2, 121.8, 114.5, 113.6, 111.9, 95.0, 











 To dienone 2.4.36 (0.38 g, 0.89 mmol) in 1,2-DCE (8.9 mL) under argon was 
added AcBr (0.10 mL, 1.3 mmol).  The solution was heated at 60 oC for 6 hrs.  The 
solution was cooled to room temperature, and saturated aqueous NaHCO3 (15 mL) was 
added to neutralize the acid.  The aqueous layer was extracted with CH2Cl2 (2 X 10 mL).  
The organic extract was washed with H2O (5 mL), dried (Na2SO4), filtered and 
concentrated by rotary evaporation.  Purificaton by column chromatography (SiO2, 20-
25% EtOAc in hexanes) yielded the title compound as a yellow solid (0.24 g, 64%).  Rf  = 
0.29  (30% EtOAc in hexane) Mp. 112-115 oC.  IR (thin film) 2959, 2924, 2835, 1710, 
1616, 1506 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.37–7.27 (6H, m), 7.23 (2H, dd, J = 
2.1, 6.7 Hz), 6.81 (2H, dd, J = 1.8, 6.1 Hz), 6.21 (1H, d, J = 2.0 Hz), 6.08 (1H, d, J = 1.8 
Hz), 4.12 (1H, s), 3.86 (3H, s), 3.79 (3H, s), 3.76 (3H, s), 1.97 (3H, s).  13C NMR(75 
MHz, CDCl3) δ 203.7, 163.6, 162.6, 160.9, 159.0, 158.0, 139.0, 132.6, 129.8, 129.1, 
128.9, 128.1, 126.0, 123.9, 113.9, 103.2, 97.2, 92.2, 88.6, 77.3, 60.4, 55.8, 55.6, 55.3, 













 To cyclopentenone 2.4.38 (0.36g, 0.84mmol) in CH3CN (10 mL) and H2O (5 mL) 
at room temperature under argon was added ceric ammonium nitrate (0.97g, 1.77 mmol) 
in water (5 mL).  The solution was stirred at room temperature for 20 minutes when a 
white powdery solid crashed out. Water (20 mL) was added and the solid was filtered and 
washed with water (3 x 10 mL) to give the title compound as an off-white solid (0.33 g, 
88%).  Rf  = 0.12  (30% EtOAc in hexane) Mp. 186-189 oC.  IR (thin film) 3442, 2960, 
2936, 2838, 1714, 1623 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.31 (5H, s), 7.28 (2H, d, J 
= 8.8 Hz), 6.90 (2H, d, J = 8.8 Hz), 6.16 (1H, d, J = 2.2 Hz), 6.07 (1H, d, J = 1.5 Hz), 
3.83 (3H, s), 3.80 (3H, s), 3.78 (3H, s), 2.06 (3H, s).  13C NMR(75 MHz, CDCl3) δ 202.0, 
164.0, 160.9, 160.2, 159.5, 158.5, 138.2, 133.1, 129.4, 129.3, 128.3, 127.6, 127.1, 113.8, 
99.1, 93.2, 92.5, 88.6, 85.9, 55.7, 55.6, 55.2, 10.5.  HRMS calculated for C27H25O6 (MH+) 















 To cyclopentenone 2.4.39 (0.08 g, 0.18mmol) in EtOH (2 mL) at room temperature 
was added NaBH4 (0.03 g, 0.87 mmol).  The solution was stirred at room temperature for 
20 minutes then poured onto ice water (5 mL).  Saturated ammonium chloride (4 mL) 
was added and the aqueous layer was extracted with EtOAc (2 X 10 mL). The organic 
layer was washed with brine (3 mL), dried (Na2SO4), filtered and concentrated by rotary 
evaporation to give the title compound as a white solid (0.08 g, 100%).  Rf  = 0.25 (50% 
EtOAc in hexane) Mp. 123-126 oC.  IR (thin film) 3521, 3455, 2964, 2936, 2841, 1611, 
1511cm-1.  1H NMR (300 MHz, CDCl3) δ 7.29 (2H, d, J = 8.1 Hz ), 7.24-7.15 (5H, m), 
6.88 (2H, d, J = 8.8 Hz), 6.23 (1H, d, J = 2.2 Hz), 6.13 (1H, d, J = 1.5 Hz), 5.08 (1H, s), 
3.89 (3H, s), 3.80 (3H, s), 3.78 (3H, s), 1.91 (3H, s).  13C NMR(75 MHz, CDCl3) δ 163.8, 
159.3, 157.2, 141.8, 136.1, 134.8, 131.6, 129.4, 129.0, 128.2, 127.8, 127.2, 113.9, 107.2, 
92.5, 92.1, 89.4, 89.3, 85.8, 55.8, 55.7, 55.2, 12.4.  HRMS calculated for C27H27O6 (MH+) 














 To diol 2.4.41 (49.4 mg, 0.11 mmol) in CH2Cl2 (1 mL) under argon at room 
temperature was added pyridine (0.5 mL), acetic anhydride (0.06 mL, 0.66 mmol) and 
DMAP (1 crystal).  The reaction mixture was stirred at room temperature for 1.5 hours, 
then poured onto water (3 mL) and extracted with CH2Cl2 (5 mL).  The organic layer was 
concentrated by rotary evaporation and dried under vacuum to yield the title compound 
as a white solid (54.2 mg, 100%) that was used without further purification.  Mp. 134-
135 oC.  Rf = 0.26 (50% EtOAc in hexane).  IR (thin film) 3480, 2956, 2924, 2842, 1739, 
1623, 1596, 1513 cm-1.  1H NMR (300 MHz, CDCl3) δ 7.28 (2H, d, J = 2.2, 8.8 Hz), 
7.24-7.18 (5H, m), 6.85 (2H, d, J = 2.2, 8.8 Hz), 6.26 (1H, s), 6.20 (1H, d, J = 2.2 Hz), 
6.06 (1H, d, J = 2.2 Hz), 3.79 (3H, s), 3.77 (6H, s), 2.22 (3H, s), 1.80 (3H, s).  13C NMR 
(75 MHz, CDCl3) δ 171.2, 163.6, 161.0, 159.2, 158.3, 139.5, 137.8, 134.5, 129.4, 128.2, 
127.9, 127.5, 123.9, 113.6, 104.0, 92.2, 90.7, 88.6, 88.5, 86.6, 55.6, 55.5, 55.1, 21.1, 12.4. 















To dienone 2.4.21 (14.0 mg, 0.03 mmol) in dry 1,2-dichloroethane (1 mL) was 
added (-)-limonene (0.03 mL, 0.17 mmol) and benzoyl bromide (0.02 mL, 0.17 mmol).  
The reaction mixture was heated to 75 oC for 30 hrs, then cooled to room temperature.  
The mixture was poured onto water (3 mL) and diluted with CH2Cl2 (3 mL).  The layers 
were separated and the organic layer was washed with sat. aqueous NaHCO3 (2 mL) and 
brine (2 mL).  The organic layer was dried (Na2SO4), filtered and concentrated by rotary 
evaporation.  Purification by column chromatography (SiO2, 20% EtOAc in hexanes) 
yielded 2.4.31 as a light yellow foam (2.8 mg, 20%) Rf = 0.25 (30% EtOAc in hexanes) 
IR (thin film) 2961, 2924, 2845, 1710, 1600, 1505 cm-1.  1H NMR (300 MHz, CDCl3) δ 
7.68 (2H, dd, J = 2.2, 8.8 Hz), 7.49-7.30 (5H, m), 6.84 (2H, dd, J = 2.2, 8.8 Hz), 6.81 
(1H, s), 6.19 (1H, d,  J = 1.5 Hz), 6.09 (1H, d, J = 1.5 Hz), 4.05 (1H, s), 3.85 (3H, s), 3.78 
(6H, s).  13C NMR (75 MHz, CDCl3) δ 202.7, 168.6, 162.6, 161.2, 159.2, 158.0, 133.7, 
132.9, 130.2, 129.5, 128.6, 128.5, 125.8, 114.2, 102.8, 97.4, 92.4, 88.5, 62.5, 55.8, 55.6, 












  To ketone 2.4.31 (11.2 mg, 0.03 mmol) in MeCN (0.3 mL) and H20 (0.3 mL) under 
argon at room temperature was added ceric ammonium nitrate (32.6 mg, 0.06 mmol) in 
H20 (0.3 mL).  The reaction mixture was stirred at room temperature for 20 min when 
water (3 mL) was added.  The aqueous layer was extracted with EtOAc (3 mL), dried 
(Na2SO4), filtered and concentrated. Purification by flash column chromatography (SiO2, 
30-40% EtOAc in hexane) yielded the title compound as a light yellow solid (5.2 mg, 






















 To NaH (436 mg, 60 % dispersion in mineral oil, 10.9 mmol) in dry THF (15 mL) 
at 0 oC was added MeOH (0.440 mL, 10.9 mmol) dropwise.  The solution was warmed to 
room temperature over 20 minutes.  Paraformaldehyde (654 mg, 21.8 mmol) was added 
to the reaction mixture, followed by dienone 2.4.21 (904 mg, 2.2 mmol) in THF (5 mL).  
Stirred at room temperature for 22 hours.  The reaction mixture was poured onto water 
(50 mL) and extracted with Et2O (50 mL).  The organic phase was washed with 2N 
NaOH (2 x 20 mL) and brine (10 mL), then dried (Na2SO4), filtered and concentrated.  
The title compound 2.4.53 was obtained as a yellow wax (1.05 g, 100%).  Rf = 0.46 (30% 
EtOAc in hexanes).  IR (thin film) 2924, 1652, 1616, 1505 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.69 (2H, dd, J = 2.0, 8.0 Hz), 7.61 (1H, s), 7.47-7.34 (5H, m), 6.91 (2H, dd, J 
= 2.0, 8.0 Hz), 6.70 (1H, d, J = 2.2 Hz), 6.30 (1H, d, J = 2.2 Hz), 4.45 (2H, s), 3.87 (3H, 
s), 3.82 (3H, s), 3.74 (3H, s), 3.52 (3H, s).  13C NMR (75 MHz, CDCl3) δ 195.1, 159.9, 
159.5, 155.1, 153.5, 148.3, 138.3, 130.1, 129.5, 129.0, 128.5, 128.4, 128.2, 127.9, 127.6, 
126.9, 114.1, 94.7, 87.9, 65.1, 58.4, 55.8, 55.5, 55.3.  HRMS calculated for C28H27O6 













 To dienone 2.4.53 (21.0 mg, 0.05 mmol) in 1,2-DCE (1.0 mL) under argon at 
room temperature was added cyclohexene (0.01 mL, 0.14 mmol) and acetyl bromide 
(0.02mL, 0.23 mmol).  The reaction mixture was warmed to 45 oC for 1 hour.  The 
solution was allowed to cool to room temperature, then was diluted with CH2Cl2 (3 mL), 
and washed with saturated NaHCO3.  The organic layer was dried (Na2SO4), filtered and 
concentrated.  Purification by flash column chromatography (SiO2 10-20% EtOAc in 
hexanes) yielded the title compound 2.4.54 as a yellow wax (25.3 mg, 97%).  Rf = 0.46 
(30% EtOAc in hexanes)  IR (thin film) 2932, 2849, 1652, 1615, 1505 cm-1.  1H NMR 
(300 MHz, CDCl3) δ 7.69 (2H, d, J = 8.8 Hz), 7.64-7.38 (6H, m), 6.90 (2H, d, J = 8.8 
Hz), 6.69 (1H, d, J = 2.2 Hz), 6.29 (1H, d, J = 2.2 Hz), 4.59 (2H, s), 3.86 (3H, s), 3.81 
(3H, s), 3.77 (3H, s).  13C NMR (75 MHz, CDCl3) δ 197.8, 168.2, 164.2, 160.1, 159.6, 
153.7, 147.1, 137.6, 132.6, 129.8, 128.8, 128.5, 128.3, 128.0, 127.5, 114.1, 100.9, 94.7, 
87.8, 55.8, 55.6, 55.3, 29.7.  HRMS calculated for C27H23O5BrNa (MH+) 529.0629.  











 To (-)-limonene (0.140 mL, 0.870 mmol) and acetyl bromide (0.160 mL, 2.20 
mmol) in 1,2-dichloroethane (0.5 mL) at room temperature was added dienone 2.4.53 
(200 mg, 0.437 mmol) in 1,2-dichloroethane (3.0 mL).  The solution was heated to 65 oC 
for 6 hours, then cooled to room temperature.  Water (5 mL) was added.  The organic 
layer was separated and the aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The 
combined organic layers were washed with sat. NaHCO3 (3 mL), dried (Na2SO4), filtered 
and concentrated to give crude 2.4.55 and 2.4.56. 
Brown oil. IR (thin film) 2922, 2843, 1771, 1699, 1652, 1604, 1506 cm-1.  1H NMR (300 
MHz, CDCl3) δ 8.11 (1H, d, J = 1.5 Hz), 8.08 (1H, d, J = 1.5 Hz), 7.45-7.13 (14H, m), 
6.64 (2H, dd, J = 1.8, 8.8 Hz), 6.63 (2H, dd, J = 2.0, 8.8), 6.46 (1H, d, J = 2.2 Hz), 6.45 
(1H, d, J = 2.2 Hz), 6.39 (1H, d, J = 2.2 Hz), 6.32 (1H, d, J = 2.2 Hz), 5.22 (1H, d, J = 1.5 
Hz), 5.15 (1H, d, J = 1.5 Hz), 3.87 (3H, s), 3.82 (3H, s), 3.73 (3H, s), 3.70 (3H, s), 3.69 
(3H, s), 3.40 (3H, s), 2.16 (3H, s), 2.08 (3H, s).  LRMS found for C31H29O8 (MH+) 529.  
 The material was then dissolved in dioxane (10 mL) and 2N NaOH (3 mL) was 
added.  The reaction mixture was stirred at room temperature for 45 minutes and then 
poured onto 1N HCl (10 mL).  The aqueous layer was extracted with EtOAc (2 x 10 mL), 
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followed by washing the organic extracts with brine (3 mL).  The organic layer was dried 
(Na2SO4), filtered, and concentrated to give a mixture of 2.4.57 and 2.4.58.   
Colorless foam. IR (thin film) 3320 (br), 2835, 1683, 1653, 1602, 1506 cm-1.  1H NMR 
(300 MHz, CDCl3) δ 7.35-7.07(14H, m), 6.96 (2H, d, J = 9.5 Hz), 6.65 (2H, d, J = 9.5 
Hz), 6.63 (2H, d, J = 8.8 Hz), 6.32 (1H, d, J = 3 Hz), 6.22 (1H, d, J = 2.2 Hz), 6.12 (1H, 
d, J = 1.5 Hz), 5.95 (1H, d, J = 2.2 Hz), 5.08 (1H, s), 4.90 (1H, s), 3.82 (6H, s), 3.70 (3H, 
s), 3.69 (3H, s), 3.54 (3H, s), 3.12 (3H, s).  13C NMR (75 MHz, CDCl3) δ 200.9, 199.7, 
165.3, 162.0, 160.5, 158.9, 158.7, 158.6, 158.0, 157.2, 155.6, 141.2, 140.1, 133.3, 130.5, 
130.2, 129.9, 129.7, 129.4, 129.1, 128.9, 128.4, 128.2, 128.1, 128.0, 127.7, 127.5, 127.3, 
127.0, 126.8 118.4, 113.6, 113.4, 102.5, 95.9, 94.9, 92.9, 92.5, 60.4, 55.6, 55.3, 55.1, 
54.8, 50.2, 29.7, 21.0. HRMS calculated for C27H25O6 (MH+) 445.1640.  Found 
445.1651.     
 The crude material was then taken up in CH3CN (3 mL) and MeOH (0.3 mL). 
Diisopropylethylamine (0.17 mL, 0.96 mmol) and trimethylsilyldiazomethane (2M in 
Et2O, 0.48 mL, 0.96 mmol) were added.  The solution was stirred at room temperature for 
17 hours. Water (5 mL) was added and the aqueous solution was extracted with EtOAc (2 
X 10 mL).  The organic layer was dried (Na2SO4), filtered and concentrated.  Purification 
by flash column chromatography (SiO2 30-50% EtOAc in hexanes) yielded the title 
compound 2.4.59 as a yellow solid (46.7 mg, 23%).  Rf = 0.11 (50% EtOAc in hexanes) 
Mp. 182-184 oC  IR (thin film) 3427, 2838, 1695, 1603 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.36 (2H, d, J = 7.4 Hz), 7.22 (2H, d, J = 8.8 Hz), 7.25-7.12 (4H, m), 6.60 (2H, 
d, J = 8.8 Hz), 6.24 (1H, d, J = 2.2 Hz), 6.16 (1H, d,  J = 2.2 Hz), 5.08 (1H, s), 3.85 (3H, 
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s), 3.78 (3H, s), 3.72 (3H, s), 3.67 (3H, s), 3.56 (3H, s).  13C NMR (75 MHz, CDCl3) δ 
195.8, 161.8, 161.5, 160.0, 159.1, 158.5, 152.2, 141.5, 135.6, 129.9, 128.2, 127.5, 126.2, 
119.9, 113.3, 106.8, 91.5, 91.3, 77.2, 61.6, 55.9, 55.3, 55.0, 49.1, 29.7.  HRMS calculated 






























 To ketone 2.4.34 (21.7 mg, 0.05 mmol) in 1,4-dioxane (0.5 mL) was added 
benzaldehyde (0.01 mL, 0.10 mmol) and concentrated HCl (2 drops).  Stirred at room 
temperature for 3 days.  Water (2 mL) was added and the aqueous layer was extracted 
with EtOAc (2 x 5 mL).  The organic layers were dried (Na2SO4), filtered and 
concentrated. Purification by flash column chromatography (SiO2, 10% EtOAc in 
hexane) yielded the title compound as a yellow wax (12.6 mg, 50%). Rf = 0.41 (30% 
EtOAc in hexane). IR (thin film) 3063, 3029, 2933, 1654, 1616, 1496 cm-1.  1H NMR 
(300 MHz, CDCl3) δ 7.67 (1H, s), 7.54 (2H, dd, J = 2.2, 8.8 Hz), 7.30-7.24 (10H, m), 
6.82 (2H, dd, J = 2.2, 8.8 Hz), 6.69 (1H, d, J = 1.5 Hz), 6.29 (1H, d, J = 1.5 Hz), 4.13 
(2H, s), 3.87 (3H, s), 3.81 (3H, s), 3.68 (3H, s). 13C NMR (75 MHz, CDCl3) δ 195.5, 
160.1, 159.4, 155.1, 153.5, 150.6, 146.4, 140.8, 140.1, 139.3, 135.3, 129.4, 129.0, 128.8, 
128.4, 127.7, 127.5, 126.9, 125.9, 114.0, 94.6, 87.9, 87.8, 55.8, 55.4, 55.2, 31.7. HRMS 













 To dienone 2.4.60 (23.1 mg, 0.046mmol) in 1,2-DCE (1.0 mL) under argon at room 
temperature was added acetyl bromide (0.02 mL, 0.23 mmol).  The reaction mixture was 
heated to 65 oC for 4 hours, then cooled to room temperature.  Water (3 mL) was added 
and the aqueous layer was extracted with CH2Cl2 (2 x 5 mL).  The organic layers were 
dried (Na2SO4), filtered and concentrated. Purification by flash column chromatography 
(SiO2, 10% EtOAc in hexane) yielded the title compound as a light yellow foam (12.6 
mg, 50%). Rf = 0.43 (50% EtOAc in hexane). IR (thin film) 2983, 2925, 2864, 1763, 
1683, 1606, 1506 cm-1.  1H NMR  (1:1 mix) (300 MHz, CDCl3) δ 7.59-7.42 (6H, m), 
7.35-7.20 (10H, m), 7.18-7.04 (10H, m), 6.69 (2H, dd, J = 2.2, 8.8 Hz), 6.68 (2H, dd, J = 
2.2, 8.8 Hz), 6.45 (1H, d, J = 1.5 Hz), 6.42 (1H, d, J = 1.5 Hz), 6.34 (1H, d, J = 1.5 Hz), 
6.30 (1H, d, J = 1.5 Hz), 5.41 (1H, s), 5.37 (1H, s), 3.88(3H, s), 3.81 (3H, s), 3.79 (3H, s) 
3.75 (3H, s), 3.74 (3H, s), 3.39 (3H, s)2.17 (3H, s), 1.95 (3H, s). HRMS calculated for 
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X-ray Experimental for C27H26O5:  Crystals grew as long, colorless laths by slow 
evaporation from ethyl acetate/hexanes.  The data crystal was cut from a larger crystal 
and had approximate dimensions; 0.29 x 0.14 x 0.06 mm.  The data were collected on a 
Nonius Kappa CCD diffractometer using a graphite monochromator with MoKa radiation 
(l = 0.71073Å).  A total of 155 frames of data were collected using w-scans with a scan 
range of 2° and a counting time of 114 seconds per frame.  The data were collected at 153 
K using an Oxford Cryostream low temperature device.  Details of crystal data, data 
collection and structure refinement are listed in Table 1.  Data reduction were performed 
using DENZO-SMN.1  The structure was solved by direct methods using SIR972 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-97.3  The hydrogen atoms on carbon were calculated in 
ideal positions with isotropic displacement parameters set to 1.2xUeq of the attached 
atom (1.5xUeq for methyl hydrogen atoms).  The function, Σw(|Fo|2 - |Fc|2)2, was 
minimized, where w = 1/[(s(Fo))2 + (0.044*P)2] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) 
refined to 0.175, with R(F) equal to 0.0720 and a goodness of fit, S, = 1.00.  Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.4  The data 
were corrected for secondary extinction effects.  The correction takes the form:  Fcorr = 
kFc/[1 + (4.2(18)x10-6)* Fc2 l3/(sin2q)]0.25 where k is the overall scale factor.  Neutral 
atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).5  All figures were 
generated using SHELXTL/PC.6  Tables of positional and thermal parameters, bond 
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lengths and angles, torsion angles, figures and lists of observed and calculated structure 






















Supplementary Table 1.  Crystal data and structure refinement for 2.1.6. 
 
Empirical formula  C27 H26 O5 
Formula weight  430.48 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.972(2) Å a= 63.741(8)°. 
 b = 10.948(2) Å b= 64.666(6)°. 
 c = 11.812(2) Å g = 64.291(7)°. 
Volume 1096.5(3) Å3 
Z 2 
Density (calculated) 1.304 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 456 
Crystal size 0.24 x 0.14 x 0.06 mm 
Theta range for data collection 2.01 to 25.00°. 
Index ranges -12<=h<=12, -11<=k<=12, -13<=l<=13 
Reflections collected 5870 
Independent reflections 3785 [R(int) = 0.0781] 
Completeness to theta = 25.00° 98.1 %  
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Max. and min. transmission 0.9947 and 0.9789 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3785 / 0 / 294 
Goodness-of-fit on F2 0.995 
Final R indices [I>2sigma(I)] R1 = 0.0720, wR2 = 0.1258 
R indices (all data) R1 = 0.2227, wR2 = 0.1752 
Extinction coefficient 4.2(18)x10-6 
















Supplementary Table 2.  Atomic coordinates for 2.1.6 
Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.1.6.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O1 4217(3) 2374(3) 3883(3) 44(1) 
C2 2717(5) 2986(5) 4461(4) 42(1) 
C3 2142(6) 3948(5) 3257(4) 44(1) 
C4 3255(5) 3568(5) 2147(4) 42(1) 
C5 3359(5) 3945(5) 813(5) 41(1) 
C6 4626(5) 3458(5) -33(5) 48(1) 
C7 5826(5) 2618(5) 417(5) 46(1) 
C8 5758(5) 2189(5) 1741(4) 46(1) 
C9 4447(5) 2694(5) 2555(4) 40(1) 
O10 951(4) 4803(4) 3339(3) 53(1) 
O11 2150(3) 4790(3) 474(3) 52(1) 
C12 2194(5) 5198(5) -876(4) 61(2) 
O13 7034(4) 2235(3) -529(3) 59(1) 
C14 8355(5) 1620(5) -217(5) 66(2) 
C15 2023(5) 1784(5) 5219(4) 39(1) 
C16 575(5) 2084(5) 5752(4) 48(1) 
C17 -85(5) 1017(6) 6431(4) 48(1) 
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C18 732(6) -380(6) 6569(5) 47(1) 
C19 2187(5) -725(5) 6064(5) 48(1) 
C20 2820(5) 358(5) 5388(4) 44(1) 
O21 191(4) -1528(3) 7263(3) 61(1) 
C22 -1252(6) -1262(6) 7402(5) 69(2) 
C23 2433(5) 3810(5) 5370(4) 44(1) 
C24 2831(5) 2809(5) 6646(5) 41(1) 
C25 1788(5) 2670(5) 7851(5) 50(1) 
C26 2130(6) 1818(5) 9016(5) 59(2) 
C27 3529(6) 1076(5) 8979(5) 58(2) 
C28 4569(6) 1194(5) 7791(5) 60(2) 
C29 4226(5) 2064(5) 6629(5) 50(1) 
C30 3012(5) 5056(5) 4766(5) 49(1) 
C31 3887(6) 5402(6) 3611(6) 81(2) 
C32 2453(6) 5975(5) 5643(5) 63(2) 
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X-ray Experimental for C27H24O5:  Crystals grew as colorless prisms by slow evaporation 
from ethyl acetate/hexanes.  The data crystal was cut from a larger crystal and had 
approximate dimensions; 0.25 x 0.12 x 0.04 mm.  The data were collected on a Nonius 
Kappa CCD diffractometer using a graphite monochromator with MoKa radiation (l = 
0.71073Å).  A total of 213 frames of data were collected using w-scans with a scan range 
of 1.5° and a counting time of 252 seconds per frame.  The data were collected at 153 K 
using an Oxford Cryostream low temperature device.  Details of crystal data, data 
collection and structure refinement are listed in Table 3.  Data reduction were performed 
using DENZO-SMN.1  The structure was solved by direct methods using SIR972 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-97.3  The hydrogen atoms were observed in a ΔF map 
and refined with isotropic displacement parameters.  The function, Σw(|Fo|2 - |Fc|2)2, 
was minimized, where w = 1/[(s(Fo))2 + (0.0449*P)2] and P = (|Fo|2 + 2|Fc|2)/3.  
Rw(F2) refined to 0.123, with R(F) equal to 0.0540 and a goodness of fit, S, = 0.992.  
Definitions used for calculating R(F), Rw(F2) and the goodness of fit, S, are given 
below.4  The data were corrected for secondary extinction effects.  The correction takes 
the form:  Fcorr = kFc/[1 + (5.7(11)x10-6)* Fc2 l3/(sin2q)]0.25 where k is the overall 
scale factor.  Neutral atom scattering factors and values used to calculate the linear 
absorption coefficient are from the International Tables for X-ray Crystallography 
(1992).5  All figures were generated using SHELXTL/PC.6  Tables of positional and 
thermal parameters, bond lengths and angles, torsion angles, figures and lists of observed 
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Supplementary Table 3.  Crystal data and structure refinement for 2.4.38. 
 
Empirical formula  C27 H24 O5 
Formula weight  428.46 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 12.3190(6) Å a= 90°. 
 b = 10.3129(6) Å b= 102.139(4)°. 
 c = 17.3538(9) Å g = 90°. 
Volume 2155.4(2) Å3 
Z 4 
Density (calculated) 1.320 Mg/m3 
Absorption coefficient 0.091 mm-1 
F(000) 904 
Crystal size 0.25 x 0.12 x 0.04 mm 
Theta range for data collection 2.31 to 27.42°. 
Index ranges -15<=h<=15, -12<=k<=13, -22<=l<=22 
Reflections collected 8721 
Independent reflections 4851 [R(int) = 0.0771] 
Completeness to theta = 27.42° 98.8 %  
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Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4851 / 0 / 386 
Goodness-of-fit on F2 0.992 
Final R indices [I>2sigma(I)] R1 = 0.0540, wR2 = 0.0961 
R indices (all data) R1 = 0.1481, wR2 = 0.1227 
Extinction coefficient 5.7(11)x10-6 
Largest diff. peak and hole 0.199 and -0.175 e.Å-3 
 206 
Supplementary Table 4. Atomic coordinates for 2.4.38   
Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.4.38.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O1 8144(1) 6483(1) 5968(1) 37(1) 
C2 7301(2) 7474(2) 5695(1) 34(1) 
C3 6573(2) 6996(2) 4920(1) 34(1) 
C4 5497(2) 6933(2) 4950(1) 36(1) 
C5 5352(2) 7350(2) 5739(1) 36(1) 
C6 6489(2) 7466(2) 6276(1) 36(1) 
C7 6863(2) 6263(2) 6747(1) 35(1) 
C8 6457(2) 5641(2) 7350(1) 37(1) 
C9 6980(2) 4539(2) 7694(1) 40(1) 
C10 7906(2) 4049(2) 7443(1) 39(1) 
C11 8339(2) 4649(2) 6856(1) 37(1) 
C12 7787(2) 5751(2) 6533(1) 35(1) 
C13 7868(2) 8762(2) 5630(1) 33(1) 
C14 7253(2) 9819(2) 5299(1) 39(1) 
C15 7739(2) 11001(2) 5201(1) 40(1) 
C16 8874(2) 11143(2) 5461(1) 39(1) 
C17 9503(2) 10102(2) 5815(1) 41(1) 
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C18 8997(2) 8921(3) 5885(1) 38(1) 
O19 9448(1) 12262(2) 5403(1) 51(1) 
C20 8870(3) 13270(3) 4912(2) 59(1) 
C21 7075(2) 6599(2) 4252(1) 36(1) 
C22 7807(2) 7389(3) 3956(1) 44(1) 
C23 8242(2) 6998(3) 3323(1) 50(1) 
C24 7984(2) 5799(3) 2987(1) 51(1) 
C25 7278(2) 4993(3) 3282(1) 53(1) 
C26 6812(2) 5396(3) 3901(1) 48(1) 
C27 4517(2) 6588(3) 4317(1) 47(1) 
O28 4466(1) 7575(2) 5918(1) 46(1) 
O29 5547(1) 6197(2) 7549(1) 44(1) 
C30 5129(3) 5572(3) 8161(2) 54(1) 
O31 8356(1) 2949(1) 7826(1) 46(1) 






















X-ray Experimental for C27H24O6:  Crystals grew as colorless laths by slow evaporation 
from ethyl acetate/hexanes.  The data crystal was cut from a cluster of crystals and had 
approximate dimensions; 0.25 x 0.09 x 0.05 mm.  The data were collected on a Nonius 
Kappa CCD diffractometer using a graphite monochromator with MoKa radiation (l = 
0.71073Å).  A total of 186 frames of data were collected using w-scans with a scan range 
of 2° and a counting time of 104 seconds per frame.  The data were collected at 153 K 
using an Oxford Cryostream low temperature device.  Details of crystal data, data 
collection and structure refinement are listed in Table 5.  Data reduction were performed 
using DENZO-SMN.1  The structure was solved by direct methods using SIR972 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-97.3  The hydrogen atoms were located in a ΔF map and 
refined with isotropic displacement parameters.  The function, Σw(|Fo|2 - |Fc|2)2, was 
minimized, where w = 1/[(s(Fo))2 + (0.0338*P)2] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) 
refined to 0.126, with R(F) equal to 0.0548 and a goodness of fit, S, = 0.957.  Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.4  The data 
were corrected for secondary extinction effects.  The correction takes the form:  Fcorr = 
kFc/[1  +  (1.5(2)x10-5)* Fc2 l3/(sin2q)]0.25 where k is the overall scale factor.  Neutral 
atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).5  All figures were 
generated using SHELXTL/PC.6  Tables of positional and thermal parameters, bond 
 210 
lengths and angles, torsion angles, figures and lists of observed and calculated structure 






















Supplementary Table 5.  Crystal data and structure refinement for 2.4.39. 
 
Empirical formula  C27 H24 O6 
Formula weight  444.46 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.2737(5) Å a= 80.793(2)°. 
 b = 10.3745(4) Å b= 78.723(2)°. 
 c = 10.5840(5) Å g = 85.817(2)°. 
Volume 1091.05(9) Å3 
Z 2 
Density (calculated) 1.353 Mg/m3 
Absorption coefficient 0.095 mm-1 
F(000) 468 
Crystal size 0.25 x 0.09 x 0.05 mm3 
Theta range for data collection 1.98 to 27.50°. 
Index ranges -13<=h<=12, -13<=k<=11, -13<=l<=11 
Reflections collected 7248 
Independent reflections 4900 [R(int) = 0.0539] 
Completeness to theta = 27.50° 97.4 %  
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Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4900 / 0 / 395 
Goodness-of-fit on F2 0.957 
Final R indices [I>2sigma(I)] R1 = 0.0548, wR2 = 0.0932 
R indices (all data) R1 = 0.1841, wR2 = 0.1255 
Extinction coefficient 1.45(17)x10-5 
Largest diff. peak and hole 0.236 and -0.259 e.Å-3 
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Supplementary Table 6. Atomic coordinates for 2.4.39   
Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.4.39.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O1 921(2) 5413(2) 3414(2) 27(1) 
C2 1751(3) 4338(3) 2902(3) 25(1) 
C3 887(3) 3664(2) 2202(3) 25(1) 
C4 1444(3) 3600(3) 958(3) 26(1) 
C5 2721(3) 4248(3) 635(3) 26(1) 
C6 2848(3) 4971(3) 1755(2) 24(1) 
C7 2305(3) 6356(3) 1565(3) 23(1) 
C8 2739(3) 7439(3) 669(3) 27(1) 
C9 2040(3) 8639(3) 723(3) 30(1) 
C10 888(3) 8729(3) 1666(3) 27(1) 
C11 444(3) 7668(3) 2595(3) 27(1) 
C12 1203(3) 6510(3) 2519(3) 25(1) 
C13 2312(2) 3507(3) 3988(3) 25(1) 
C14 2718(3) 2200(3) 3914(3) 26(1) 
C15 3379(3) 1483(3) 4835(3) 31(1) 
C16 3641(3) 2059(3) 5844(3) 28(1) 
C17 3220(3) 3326(3) 5950(3) 29(1) 
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C18 2560(3) 4048(3) 5030(3) 31(1) 
O19 4356(2) 1277(2) 6680(2) 37(1) 
C20 4849(4) 1896(4) 7579(4) 43(1) 
C21 -460(3) 3277(3) 2873(3) 27(1) 
C22 -1543(3) 3669(3) 2243(3) 31(1) 
C23 -2813(3) 3368(3) 2856(3) 35(1) 
C24 -3045(3) 2652(3) 4082(3) 38(1) 
C25 -2011(3) 2254(3) 4721(3) 36(1) 
C26 -718(3) 2582(3) 4123(3) 32(1) 
C27 974(4) 2972(4) -48(3) 35(1) 
O28 3546(2) 4231(2) -363(2) 33(1) 
O29 4143(2) 4811(2) 2055(2) 30(1) 
O30 3864(2) 7230(2) -209(2) 33(1) 
C31 4432(4) 8331(4) -1086(3) 40(1) 
O32 248(2) 9930(2) 1595(2) 37(1) 























X-ray Experimental for C27H26O6:  Crystals grew as colorless plates by slow evaporation 
from ether/hexanes.  The data crystal was cut from a larger crystal and had approximate 
dimensions; 0.10 x 0.10 x 0.04 mm.  The data were collected on a Nonius Kappa CCD 
diffractometer using a graphite monochromator with MoKa radiation (l = 0.71073Å).  A 
total of 203 frames of data were collected using w-scans with a scan range of 2° and a 
counting time of 304 seconds per frame.  The data were collected at 153 K using an 
Oxford Cryostream low temperature device.  Details of crystal data, data collection and 
structure refinement are listed in Table 7.  Data reduction were performed using DENZO-
SMN.1  The structure was solved by direct methods using SIR972 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms 
using SHELXL-97.3  The hydrogen atoms on carbon were calculated in ideal positions 
with isotropic displacement parameters set to 1.2xUeq of the attached atom (1.5xUeq for 
methyl hydrogen atoms).  The hydrogen atoms on the hydroxyl oxygen atoms were 
observed in a ΔF map and refined with isotropic displacement parameters.  The function, 
Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(s(Fo))2 + (0.0366*P)2 + (0.6309*P)] 
and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.131, with R(F) equal to 0.0560 and a 
goodness of fit, S, = 1.01.  Definitions used for calculating R(F), Rw(F2) and the 
goodness of fit, S, are given below.4  The data were corrected for secondary extinction 
effects.  The correction takes the form:  Fcorr = kFc/[1 + (2.1(6)x10-6)* Fc2 
l3/(sin2q)]0.25 where k is the overall scale factor.  Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
 217 
for X-ray Crystallography (1992).5  All figures were generated using SHELXTL/PC.6  
Tables of positional and thermal parameters, bond lengths and angles, torsion angles, 


















Supplementary Table 7.  Crystal data and structure refinement for 2.4.41. 
 
Empirical formula  C27 H26 O6 
Formula weight  446.48 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.4937(3) Å a= 76.264(2)°. 
 b = 11.6062(3) Å b= 73.462(2)°. 
 c = 18.1189(6) Å g = 78.994(2)°. 
Volume 2230.95(11) Å3 
Z 4 
Density (calculated) 1.329 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 944 
Crystal size 0.10 x 0.10 x 0.04 mm3 
Theta range for data collection 2.45 to 27.43°. 
Index ranges -14<=h<=14, -14<=k<=15, -23<=l<=23 
Reflections collected 16738 
Independent reflections 9995 [R(int) = 0.0460] 
Completeness to theta = 27.43° 98.5 %  
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Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9995 / 0 / 613 
Goodness-of-fit on F2 1.007 
Final R indices [I>2sigma(I)] R1 = 0.0560, wR2 = 0.1062 
R indices (all data) R1 = 0.1275, wR2 = 0.1309 
Extinction coefficient 2.1(6)x10-6 
Largest diff. peak and hole 0.246 and -0.228 e.Å-3 
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Supplementary Table 8.  Atomic coordinates for 2.4.41  
Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.4.41.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O1A 1073(1) 337(1) 2744(1) 30(1) 
C2A 1165(2) -3(2) 1998(1) 27(1) 
C3A 1061(2) -1329(2) 2161(1) 28(1) 
C4A 2043(2) -1933(2) 1740(1) 30(1) 
C5A 2928(2) -1109(2) 1201(1) 32(1) 
C6A 2544(2) 78(2) 1495(1) 29(1) 
C7A 3120(2) 221(2) 2111(1) 27(1) 
C8A 4327(2) 326(2) 2078(1) 29(1) 
C9A 4612(2) 492(2) 2730(1) 32(1) 
C10A 3694(2) 551(2) 3419(1) 32(1) 
C11A 2481(2) 496(2) 3469(1) 31(1) 
C12A 2238(2) 345(2) 2795(1) 28(1) 
C13A 264(2) 854(2) 1595(1) 28(1) 
C14A -166(2) 517(2) 1040(1) 31(1) 
C15A -893(2) 1334(2) 614(1) 33(1) 
C16A -1204(2) 2504(2) 729(1) 33(1) 
C17A -790(2) 2853(2) 1277(1) 36(1) 
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C18A -58(2) 2020(2) 1701(1) 33(1) 
O19A -1920(1) 3241(2) 274(1) 44(1) 
C20A -2032(2) 4504(2) 258(2) 53(1) 
C21A 0(2) -1838(2) 2753(1) 32(1) 
C22A 178(2) -2918(2) 3275(1) 42(1) 
C23A -800(3) -3403(3) 3830(2) 50(1) 
C24A -1975(2) -2829(3) 3885(2) 50(1) 
C25A -2173(2) -1758(3) 3381(2) 49(1) 
C26A -1199(2) -1266(2) 2825(1) 41(1) 
C27A 2329(2) -3227(2) 1698(2) 42(1) 
O28A 4148(1) -1641(2) 1196(1) 43(1) 
O29A 2701(1) 1015(2) 819(1) 35(1) 
O30A 5169(1) 253(2) 1373(1) 37(1) 
C31A 6419(2) 333(3) 1326(2) 45(1) 
O32A 4104(1) 690(2) 4035(1) 41(1) 
C33A 3276(3) 543(3) 4795(2) 73(1) 
O1 6170(1) 3717(1) 2323(1) 26(1) 
C2 5921(2) 4106(2) 3070(1) 24(1) 
C3 5927(2) 5444(2) 2899(1) 25(1) 
C4 4901(2) 6010(2) 3297(1) 28(1) 
C5 4050(2) 5134(2) 3816(1) 29(1) 
C6 4534(2) 3969(2) 3506(1) 25(1) 
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C7 4082(2) 3824(2) 2831(1) 24(1) 
C8 2927(2) 3695(2) 2774(1) 26(1) 
C9 2783(2) 3494(2) 2086(1) 27(1) 
C10 3804(2) 3405(2) 1451(1) 26(1) 
C11 4974(2) 3493(2) 1486(1) 26(1) 
C12 5058(2) 3687(2) 2194(1) 23(1) 
C13 6826(2) 3363(2) 3514(1) 23(1) 
C14 6986(2) 3719(2) 4156(1) 29(1) 
C15 7783(2) 3040(2) 4592(1) 29(1) 
C16 8445(2) 1996(2) 4381(1) 27(1) 
C17 8305(2) 1628(2) 3739(1) 31(1) 
C18 7491(2) 2300(2) 3320(1) 28(1) 
O19 9270(1) 1256(2) 4760(1) 38(1) 
C20 9469(2) 1623(2) 5408(1) 42(1) 
C21 6962(2) 5984(2) 2296(1) 28(1) 
C22 6722(2) 6874(2) 1672(1) 38(1) 
C23 7670(2) 7350(2) 1083(1) 46(1) 
C24 8868(2) 6940(3) 1108(2) 51(1) 
C25 9119(2) 6054(3) 1718(2) 50(1) 
C26 8175(2) 5579(2) 2307(1) 37(1) 
C27 4568(2) 7313(2) 3311(2) 41(1) 
O28 2806(1) 5605(2) 3825(1) 42(1) 
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O29 4337(1) 3010(2) 4160(1) 33(1) 
O30 1980(1) 3778(1) 3432(1) 33(1) 
C31 793(2) 3603(2) 3405(1) 39(1) 
O32 3554(1) 3203(1) 798(1) 32(1) 






























X-ray Experimental for C29H28O6:  Crystals grew as pale yellow prisms by slow 
evaporation from ethyl acetate/hexanes.  The data crystal was cut from a larger crystal 
and had approximate dimensions; 0.22 x 0.20 x 0.16 mm.  The data were collected on a 
Nonius Kappa CCD diffractometer using a graphite monochromator with MoKa radiation 
(l = 0.71073Å).  A total of 252 frames of data were collected using w-scans with a scan 
range of 2° and a counting time of 66 seconds per frame.  The data were collected at 153 
K using an Oxford Cryostream low temperature device.  Details of crystal data, data 
collection and structure refinement are listed in Table 9.  Data reduction were performed 
using DENZO-SMN.1  The structure was solved by direct methods using SIR972 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-97.3  The hydrogen atoms on carbon were calculated in 
ideal positions with isotropic displacement parameters set to 1.2xUeq of the attached 
atom (1.5xUeq for methyl hydrogen atoms).  The function, Σw(|Fo|2 - |Fc|2)2, was 
minimized, where w = 1/[(s(Fo))2 + (0.0353*P)2 + (0.5662*P)] and P = (|Fo|2 + 
2|Fc|2)/3.  Rw(F2) refined to 0.112, with R(F) equal to 0.0489 and a goodness of fit, S, = 
1.01.  Definitions used for calculating R(F), Rw(F2) and the goodness of fit, S, are given 
below.4  The data were checked for secondary extinction effects but no correction was 
necessary.  Neutral atom scattering factors and values used to calculate the linear 
absorption coefficient are from the International Tables for X-ray Crystallography 
(1992).5  All figures were generated using SHELXTL/PC.6  Tables of positional and 
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thermal parameters, bond lengths and angles, torsion angles, figures and lists of observed 























Supplementary Table 9.  Crystal data and structure refinement for 2.4.59 
. 
Empirical formula  C29 H28 O6 
Formula weight  472.51 
Temperature  153(2) K 
Wavelength  0.71070 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.9524(5) Å a= 115.559(2)°. 
 b = 11.6166(4) Å b= 100.884(2)°. 
 c = 11.8930(7) Å g = 104.400(3)°. 
Volume 1243.94(10) Å3 
Z 2 
Density (calculated) 1.262 Mg/m3 
Absorption coefficient 0.088 mm-1 
F(000) 500 
Crystal size 0.22 x 0.20 x 0.16 mm 
Theta range for data collection 2.04 to 27.50°. 
Index ranges -12<=h<=14, -14<=k<=15, -15<=l<=15 
Reflections collected 9110 
Independent reflections 5646 [R(int) = 0.0201] 
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Completeness to theta = 27.50° 98.8 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5646 / 0 / 321 
Goodness-of-fit on F2 1.014 
Final R indices [I>2sigma(I)] R1 = 0.0489, wR2 = 0.0986 
R indices (all data) R1 = 0.0795, wR2 = 0.1120 

















Supplementary Table 10.  Atomic coordinates for 2.4.59 
Atomic coordinates  (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.4.59.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O1 4851(1) 125(1) 8197(1) 35(1) 
O2 2779(1) 1864(1) 9930(1) 36(1) 
O3 -1419(1) -1624(1) 6822(1) 38(1) 
O4 2297(1) -145(1) 5452(1) 33(1) 
O5 1808(1) 6603(1) 8053(1) 37(1) 
O6 8540(1) 3255(1) 9077(1) 34(1) 
C1 4973(2) 1202(2) 8197(2) 25(1) 
C2 3881(2) 1712(2) 7987(1) 22(1) 
C3 4389(2) 2975(2) 8125(1) 21(1) 
C4 5891(2) 3407(2) 8344(2) 23(1) 
C5 6216(2) 2270(2) 8457(2) 24(1) 
C6 2480(2) 847(2) 7674(2) 23(1) 
C7 1937(2) 910(2) 8658(2) 25(1) 
C8 634(2) 76(2) 8351(2) 27(1) 
C9 -141(2) -861(2) 7028(2) 27(1) 
C10 373(2) -986(2) 6018(2) 27(1) 
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C11 1687(2) -126(2) 6359(2) 25(1) 
C12 2431(2) 1733(2) 10978(2) 41(1) 
C13 -2303(2) -2534(2) 5481(2) 43(1) 
C14 1643(2) -1241(2) 4113(2) 39(1) 
C15 3708(2) 3908(2) 8098(1) 22(1) 
C16 2315(2) 3554(2) 7799(2) 27(1) 
C17 1721(2) 4469(2) 7790(2) 30(1) 
C18 2488(2) 5775(2) 8085(2) 27(1) 
C19 3865(2) 6164(2) 8406(2) 28(1) 
C20 4450(2) 5238(2) 8414(2) 27(1) 
C21 2575(2) 7931(2) 8279(2) 40(1) 
C22 6235(2) 3548(2) 7212(2) 25(1) 
C23 5587(2) 2490(2) 5903(2) 33(1) 
C24 5947(2) 2616(2) 4891(2) 47(1) 
C25 6954(2) 3796(2) 5178(2) 55(1) 
C26 7603(2) 4844(2) 6466(2) 51(1) 
C27 7239(2) 4721(2) 7475(2) 36(1) 
C28 7422(2) 2228(2) 8804(2) 27(1) 
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